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ABSTRACT 
Introduction:   Neonatal encephalopathy (NE) is an important condition which may result in 
mortality or severe and permanent morbidity placing much strain on busy under-resourced 
health care services, parents and families, and the greater community. There is much debate 
on its aetiology; whether it is caused by antepartum conditions or intrapartum obstetric 
complications (known as sentinel events); and the relative contribution of intrapartum 
hypoxia. Unlike perinatal mortality, NE rates are not routinely audited by maternity facilities. 
At Mowbray Maternity Hospital, a formal audit was conducted in 2008, which measured the 
NE rate, focussed on obstetric factors associated with NE and identified avoidable factors in 
the care provided. It was thought to be of clinical value to repeat this audit to identify whether 
there were any trends in rates and the pattern of obstetric factors.    
Aims and objectives:  The aim was to describe the obstetric factors occurring in patients 
who delivered neonates at MMH, diagnosed with NE.  Specifically, it was planned to 
determine the NE rate, to describe obstetric factors occurring in these patients and to assess 
the avoidable factors related to the patients, health system and clinical management. 
 Methodology:  This was a retrospective descriptive study which included patients whose 
neonates were diagnosed with NE and were born at MMH in 2016. The diagnosis of NE was 
made according to the MMH NE protocol where NE is defined as a voltage suppression in 
amplitude-integrated electroencephalography (aEEG) or seizures; or clinical seizures or 
dystonic movements; or moderate to severe clinical signs of  NE as defined by Shankaran and 
a level of consciousness which is decreased with abnormal tone.  
 The neonates’ names were retrieved from a NE register in the neonatal unit and the 
corresponding mothers’ folders retrieved.  Data on relevant obstetric and clinical 
management factors were collected from the folders using a data collection tool developed in 
the Western Cape and all cardiotocographic tracings were assessed by the researcher. Ethics 
approval was granted by the University of Cape Town Human Research Ethics Committee 
(UCT HREC) prior to the commencement of the study. STATA 14 was used for the analysis.                                                                                                                                                
Results:  In 2016, 53 neonates with NE were identified out of 9,702 live births (LB) at 
MMH.  The NE rate was 5.5 per 1000 LB.  Of the 53 neonates, 48 maternal patient files were 
retrieved and analysed. There were 58% who had been referred to MMH from the midwife 
obstetric units (MOUs), and 42% fully managed at MMH. All patients were booked for 
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antenatal care, the mean age was 27.5 years and 50% were nulliparous. The mean gestational 
age at delivery was 39 weeks. The majority (87.5%) experienced labour, spontaneous in 
72.9% and induced in 14.6%. Antenatal complications occurred in 77.1%, the most frequent 
being   prolonged pregnancy (25%) hypertensive disorders (18.8%), antepartum haemorrhage 
(8.3%) and prelabour rupture of membranes (8.3%). Obstetric problems in labour included 
prolonged second stage of labour (25% of patients who had a second stage of labour); 
multiple vaginal examinations (28.6%) and prolonged first stage of labour (17.9%).  Fetal 
monitoring at the MOUs was done according to protocol in 70% of patients in the latent 
phase but only 12.5% of those in the active phase of labour.  At MMH, all patients in labour 
had Cardiotocograph (CTG) monitoring with 90.6% of CTGs being pathological and 6.3% 
suspicious, as assessed by the researcher.  Meconium stained liquor occurred in 40.5% of 
patients. The mode of delivery was normal vertex, (27.1%), Caesarean sections (58.3%) and 
assisted vaginal delivery (14.6%).   Most CS (71.4%) were done for pathological CTGs.  
Sentinel events occurred in 15 (31.3%) patients; approximately two-thirds occurring 
intrapartum and one- third antenatal.  Sentinel events included shoulder dystocia (10.4%), 
prolonged second stage of labour (10.4%), abruptio placenta (6.3%), cord prolapse (2.1%) 
and eclampsia (2.1%). Of the 37 (68.7%) without a sentinel event, 75.8% had a pathological 
CTG.  Considering avoidable factors, there was an ambulance delay in 42.9%, and a delay in 
accessing theatre for 53.6% of patients requiring a CS.  Poor quality CTG tracing and 
monitoring occurred in 20.8% of patients; and for 34.4%, the researcher identified an 
abnormal CTG but it was not detected by the attendant health care workers.  
Discussion and conclusion:  The NE rate for MMH is 5.5 per 1000 LBs, this is higher than 
the 3.7 found in the previous 2008 MMH study, despite a higher CS rate. Possible reasons for 
the increase include changes in case ascertainment, increased workload with same staff 
component, or a shift from perinatal hypoxic mortality to morbidity, notably NE.                                                                                        
This NE rate compares with other lower resource settings and the previous MMH audit, as 
does the high proportion of intrapartum obstetric sentinel events. This is in contrast to 
findings from high resource settings. 
Areas for service improvement include regular and ongoing intrapartum care training, 
including fetal heart monitoring, for medical and nursing staff; and addressing the health 
system issues identified. 
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1.    INTRODUCTION 
Neonatal encephalopathy (NE) is an important condition which may cause severe morbidity 
and mortality.  Hypoxic Ischaemic Encephalopathy (HIE) is one cause for NE in which   
perinatal hypoxia, cerebral ischaemia and asphyxia are thought to be causal for the 
encephalopathy. Sixty percent (%) of neonates with moderate and /or severe NE either die or 
have long term sequelae including cerebral palsy and epilepsy.  Furthermore, children with 
no motor affectation may have decreased cognition causing difficulty and problems with 
learning abilities requiring additional support at school (Kurinczuk, White-Koning & Badawi, 
2010: 329; Gane et al., 2013: 119). 
The World Health Organisation (WHO) estimates that 23% of neonatal deaths globally are 
due to hypoxia and reports that hypoxia at birth is the fifth leading cause of mortality for 
children under five years of age (Bryce et al., 2005: 1150; Gane et al., 2013: 119).  Moreover, 
30% of NE cases occurring in developed countries are due to intrapartum hypoxia whereas 
60% of NE cases in the developing world are due to hypoxia (Kurinczuk, White-Koning & 
Badawi, 2010: 337). 
It has been shown that various obstetric factors are present in the mothers of neonates with 
NE and that certain causes of HIE may be a result of substandard obstetric care.  Hence, the 
obstetric factors which may be causal for cases with encephalopathy and possible avoidable 
factors need to be identified and demonstrated (Kalume Kalangula, 2008: 30-32).  In so 
doing, there may be refinement in the management of obstetric patients in the antenatal and 
intrapartum periods and a possible resultant decrease in the NE rate; and thereby an 
improvement in neonatal outcome (Martinez-Biarge et al., 2013: e957). 
In 2008, a study at Mowbray Maternity Hospital (MMH) in Cape Town described several 
obstetric factors associated with NE and identified avoidable factors (Kalume Kalangula, 
2008).  In this study, we planned to repeat the 2008 study to identify what the current 
situation was in respect to obstetric factors occurring in neonates with NE and possible 
avoidable or modifiable factors in the obstetric management at MMH and its satellite 
midwife obstetric units (MOUs). 
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2.  LITERATURE REVIEW 
 2.1 INTRODUCTION 
In this literature review a synopsis of neonatal encephalopathy (NE) and hypoxic ischaemic 
encephalopathy (HIE) is given.  It highlights the obstetric factors occurring in neonates who 
are diagnosed with NE as well as its possible causes and avoidable or modifiable factors.  
The review sums up the challenges of ensuring quality obstetric practices and looks at the 
findings of various international, national and local articles on NE. 
Information was obtained from a number of different sources including peer-reviewed journal 
articles, electronic databases, electronic journal articles, websites and previous research 
studies.  Keywords used in the search for sources:  NE, HIE, intrapartum care, obstetric care, 
brain cooling. 
 
2.2  OVERVIEW AND DEFINITION OF HYPOXIC ISCHAEMIC ENCEPHALOPATHY 
AND NEONATAL ENCEPHALOPATHY 
HIE and NE are often used interchangeably, however they are two separate entities each with 
its own definition. 
2.2.1 HIE versus NE 
NE is defined as a condition in which there is a neurological dysfunction shortly after birth in 
a term neonate.  This is characterised by difficulty breathing, decreased tone, decreased 
reflexes and a decreased level of consciousness, with or without seizures. 
HIE is a subset of NE.  Hypoxia, cerebral ischaemia and asphyxia are important in the 
definition of HIE.  Firstly, hypoxia is due to a lack, or little, oxygen in the blood supply.  
Secondly, cerebral ischaemia refers to the decreased amount of blood supplying the brain 
resulting in a decrease in glucose which, in turn causes injury of the neurons.  Thirdly, 
asphyxia occurs when there is inadequate exchange of oxygen and carbon dioxide. Thus, 
there is an increase in carbon dioxide resulting in metabolic acidosis.  Therefore, if there are 
low Apgar scores and a low blood pH together with a recent hypoxic-ischaemic cause for the 
encephalopathy, this phenomenon is called HIE (Kurinczuk, White-Koning & Badawi, 2010: 
330). 
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 2.2.2. HIE versus cerebral palsy 
Cerebral palsy (CP) is described as a non-progressive disorder of development of posture and 
movements which is permanent.  There is a decrease in motor activity associated with 
disturbances in the developing brain of a fetus or neonate.  NE is described as having many 
causes, as alluded to previously, hypoxic injury in the intrapartum period being only one of 
them. It is further described that NE does not always lead to permanent damage, however it is 
said to be a prerequisite for linking intrapartum hypoxic injury to CP (Johnson, Blair & 
Stanley, 2011: 98). 
 
2.3 INCIDENCE 
It is difficult to determine the incidence of NE worldwide as different centres use differing 
definitions of NE and HIE.  Moreover, some studies are population-based and other hospital-
based.  An estimated global incidence of NE from various studies ranges from one to eight 
cases per 1000 live births (Kurinczuk, White-Koning & Badawi, 2010: 330).  The WHO 
reported that birth asphyxia-related neonatal deaths amount to about 920 000 every year.  Put 
differently, 23 percent (%) of the world’s neonatal deaths (four million) annually, are due to 
birth asphyxia (Bryce et al, 2005: 1150; Gane et al., 2013:119).   
In a study published in 2015 done at the largest hospital in SA, Chris Hani Baragwanath 
Academic Hospital (CHBAH), the incidence of NE was found to be 8.5/1000 live births 
(Bruckmann & Velaphi, 2015: 302).  Locally, as shown in the previous study of NE done at 
MMH, the incidence of NE in 2008 was 3,7/1000 live births (Kalume Kalangula, 2008: 29). 
When investigating trends in incidence of NE, it is noted that the trends may also be 
influenced by interventions that reduce perinatal mortality. For example (e.g.), improved fetal 
monitoring in labour and risk assessment may lead to earlier intervention which reduce rates 
of still birth and early neonatal death from hypoxia, but may result in more live newborns 
with NE. In other words, rising NE rates could be due to a shift from mortality to morbidity.  
On the other hand, in the same setting, lower rates of NE could be associated with a higher 
hypoxic-related mortality. 
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2.4  OBSTETRIC FACTORS IN NEONATES WITH NE 
Historically, there has been great debate as to whether HIE and NE have their origin in the 
antepartum or intrapartum period.  It was previously shown in a West Australian study done 
by Badawi et al. (1998) that antepartum factors alone (69%) contributed much more towards 
babies with NE than intrapartum factors alone (4%) (Badawi et al., 1998: 1557).  However, 
their definition of encephalopathy was different and broader than current definitions.  They 
included babies who had seizures at up to one week postpartum and a cord pH was not an 
obligatory criterion for diagnosing NE.  They also included certain babies with birth disorders 
and the older studies included neonates who had genetic or congenital abnormalities 
(Adamson et al., 1995: 598). 
In the Kalume Kalangula study of 2008 done at MMH, the obstetric factors identified were 
divided into antepartum and intrapartum conditions.  In the antenatal period, infections, 
prolonged rupture of membranes (PROM) and antepartum haemorrhage (APH), amongst 
others, contributed to NE.  In the intrapartum period, prolonged second stage of labour was 
the greatest contributory factor for NE (Kalume Kalungula, 2008: 30-32). 
In a study conducted by Martinez-Biarge et al. in Spain in 2011, it was shown that obstetric 
sentinel events (SE) were integral to the association of obstetric factors with NE.  SE are 
described as acute events which can cause a formerly healthy fetus of a low risk pregnancy to 
have hypoxia and or ischaemic brain damage. The SE that they studied were uterine rupture, 
abruptio placentae, cord accidents and amniotic fluid embolism (AFE). They examined the 
incidence of NE in relation to three main groups namely, SE, non-reassuring fetal status 
(NRFS), and elective Caesarean Section (CS).  They found that 71% of all the neonates who 
had NE, had an associated SE compared to 29% in the NRFS group.  There were no babies 
with NE in the CS group.  In addition, amongst the perinatal and neonatal morbidity in the SE 
group, uterine rupture accounted for most of the babies with NE, followed by abruptio 
placentae, then cord prolapse and lastly AFE.  Further, the study showed no association 
between NE and various antenatal factors: maternal age, maternal disease (e.g. diabetes and 
hypertension), complications of pregnancy (e.g. pre-eclampsia and anaemia), intra-uterine 
growth restriction (IUGR) or chorioamnionitis (Martinez-Biarge et al., 2011: 1.e1 & 1.e4). 
Martinez-Biarge et al. (2013) showed that, when comparing antepartum and intrapartum 
complications, the latter were significantly more associated with babies with NE.  These 
included PROM, thick meconium stained liquor (MSL), SE, shoulder dystocia, tight cord 
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around the neck, abnormal cardiotocograph (CTG) and vacuum delivery.  In contrast, there 
were no differences in family history (e.g. seizures), maternal conditions (e.g. thyroid 
disease) and complications during pregnancy (e.g. hypertension) between those mothers with 
babies with NE and those without.  Moreover, a gestational age (GA) of less than 37 or more 
than 41 weeks and a birth weight of less than the tenth percentile, predisposed babies to NE.  
When looking at cases and controls and their exposure to antepartum and intrapartum factors 
alone and in combination, it was shown that at least one antepartum factor was present in 
both cases and controls.  Whereas intrapartum factors alone or in combination with 
antepartum factors were present in 90% of babies with NE (Martinez-Biarge et al., 2013: 
e954 - e955).  
 
2.5  FETAL HEART RATE MONITORING 
Fetal heart rate (FHR) monitoring is of importance as it sets out to detect a compromised or 
hypoxic fetus timeously to allow for appropriate management of the patient.  To ensure a 
favourable outcome, FHR monitoring, its interpretation and its management should be 
meticulous and accurate, and the health care worker (HCW) should be sufficiently trained to 
perform it (Mahomed et al., 1994: 497; Jagau, et al., 2017:135). 
Various studies have been done to determine which methods are ideal for FHR monitoring in 
labour.  These include continuous or intermittent cardiotocograph (CTG) monitoring, doptone 
use and Pinard fetoscope (PFS) use.  These will now be discussed. 
      2.5.1 Low risk women 
In a 2017 Cochrane Library review, CTG use was compared with intermittent auscultation 
(IA) of the FHR on admission to determine fetal well-being.  It was found that admission 
CTG and IA made no obvious difference in the incidence of assisted vaginal delivery or 
perinatal mortality rate (PNMR).  Furthermore, there were no clear differences between the 
effect of the two FHR monitoring methods on the incidence and severity of NE, nor the 
incidence of seizures in the first 28 days of life.  It was thus concluded that the admission 
CTG was of no benefit to low-risk women and a recommendation was made that the 
admission CTG not be used for such women (Devane et al., 2017: 2). 
The partograph was introduced to improve monitoring in the intrapartum period.  It is a 
graphical documentation of the fetal and maternal condition and the progress of labour where 
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observations are documented at regular intervals.  Specific to FHR monitoring, the 
partograph facilitates the timeous detection of fetuses that are hypoxic.  In a study in 2017, it 
was shown that in an under-resourced and high burden of disease setting (MMH), the 
partograph was poorly completed even though HCW knew the importance of its use.  
Midwives suggested that too little time to manage many patients was the reason for 
inadequately completing the partograph.  Further, they felt insecure about their knowledge 
and highlighted the need for continuous training.  Of importance, this study showed that the 
partograph was completed better at the MOU level where hand-held devices were used for 
FHR monitoring, instead of CTGs (Jagau et al., 2017:130, 133-135).  
Similarly, Mahomed et al. (1994), in Zimbabwe, showed that the doptone was better than the 
PFS in abnormal FHR detection and thus improved fetal outcome.  Moreover, doptone use 
showed similar perinatal outcomes to CTG monitoring. They concluded that intermittent 
doptone FHR monitoring is best used in developing countries which are under-resourced 
(Mahomed et al, 1994: 500). 
In SA, the guidelines specify that in the latent phase of the first stage of labour, the FHR must 
be routinely monitored and documented every four hours, whereas in the active phase, it must 
be done every 30 minutes, before and after a contraction.  In the second stage of labour, the 
FHR should be monitored after every second contraction in low risk women (Department of 
Health, 2015: 48-49).  In the Metropole West in the Western Cape Province it is 
recommended to monitor the FHR two-hourly in the latent phase of labour; the rest of the 
monitoring remains the same as discussed above (Department of Health Western Cape 
Government, 2011: 54). 
    2.5.2 High risk women 
In addition to above, the National Institute for Clinical Excellence in UK (NICE) has 
published recommended care pathways for the intrapartum period.  They recommend that 
continuous CTG monitoring be used in high risk patients only.  These include patients with 
tachycardia of more than 120 beats per minute, temperatures of more than 38 degrees Celsius, 
suspected chorioamnionitis, severe pre-eclampsia or hypertension, etcetera (etc).  
Furthermore, the CTG tracing should be reviewed regularly and HCW should be well skilled 
in CTG interpretation and management of a patient with an abnormal CTG (National Institute 
for Health and Care Excellence (NICE) Pathways, 2019: 3-6). 
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2.6   AVOIDABLE FACTORS 
The avoidable factors that may be present in patients who have delivered babies with NE, can 
be classified using the Perinatal Problem Identification Program (PPIP) tool, used in SA (see 
appendix 3).  PPIP is an audit tool mostly used to identify avoidable factors in perinatal 
deaths at each maternity unit in SA.  It determines the mortality rates of stillbirths and 
neonates, the causes of mortality, the number of deliveries and whether there were avoidable 
factors present that could have contributed to the outcomes.  The avoidable factors are 
subdivided into patient-, medical personnel- and administrative-related factors.  Examples of 
patient, and administrative factors respectively are a patient being unbooked for antenatal 
care (ANC), delay in transfer from a clinic to the referral hospital to escalate management 
and the operating theatre (OT) being occupied resulting in delay performing Caesarean 
Section (CS).  In addition, specific to intrapartum care, two of the medical personnel-related 
avoidable factors are, 
 “fetal distress not detected intrapartum; fetus monitored” and  
“fetal distress not detected intrapartum; fetus not monitored” 
(Perinatal Problem Identification Program (PPIP), 2013). 
In the study of Kalume-Kalangula in 2008, it was found that 65% of the cases of NE were 
associated with substandard medical care.  Examples of the avoidable factors which they 
identified were inadequate FHR monitoring, delayed referral from the MOU and delayed 
management of prolonged second stage of labour (Kalume Kalangula, 2008: 29) 
 
2.7  NE SCORING 
Sarnat and Sarnat first introduced a NE classification system in the mid-1970s, which was 
used in many countries. Their classification of neonates with NE was divided into mild, 
moderate and severe, see Table 1. This system, however, was tedious and commanded good 
training in paediatrics. 
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Table 1:  Sarnat and Sarnat score 
Score    
Staging 
Clinical 
grade 
Symptoms Outcome 
I Mild Hyperalert, hyper-reactive 
May be tachycardic, have dilated pupils and 
jittery 
Symptoms should abate in 2 days and 
neurological exam be normal by 1-2 weeks 
normal 
II Moderate Lethargic, +- irritable, hypotonic 
Proximal and central weakness 
Low heart rate, small pupils, secretions 
Seizures and abnormal aEEG* common 
At least 25% 
abnormal 
with CP 
III Severe Unresponsive, flaccid, absent reflexes 
Seizures common 
Abnormal aEEG with suppressed 
background activity 
>80% 
abnormal / 
death 
MMH NE management guideline, 2016 quoted Sarnat (1976) 
*amplitude-integrated electroencephalography 
 
The Thompson NE score is a numerical tool which was introduced at the Neonatal Intensive 
Care Unit (NICU) at Groote Schuur Hospital (GSH) and is based on the Sarnat and Sarnat 
classification. It is a simple tool that may be used in developing countries and by junior staff.  
It is made up of specific signs that are found in neonates with dysfunction of the central 
nervous system (CNS), see Table 2. 
This is used to determine the condition of a neonate after asphyxia at birth.  As alluded to 
above, the set of clinical signs include neonatal tone, level of consciousness, fits, posture, 
Moro, grasp, suck, respiration and fontanelle integrity.  The lowest score is nought (normal) 
and the highest is 22. 
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Table 2:  The Thompson NE score  
                
                Score 
Sign 
 
0 
 
1 
 
2 
 
3 
Tone Normal Hyper Hypo Flaccid 
LOC Normal Hyperalert; stare Lethargic Comatosed 
Fits None < 3/day >2/day  
Posture Normal Fisting; cycling Strong distal 
flexion 
Decerebrate 
Moro Normal Partial Absent  
Grasp Normal Poor Absent  
Suck Normal Poor Absent +- bites  
Respiration Normal Hyperventilation Brief apnoea IPPV (apnoea) 
Fontenelle Normal Full; not tense Tense  
(Thompson et al, 1997: 758) 
 
Neonates with maximum scores of one to 10 have mild NE; 11 to 14 have moderate NE and 
15 to 22 have severe NE.  A maximum score of more than 10 in the first week of life is 
predictive of abnormal sequelae.  Furthermore, serial Thompson scoring is used to determine 
the clinical improvement of neonates.  In addition, it was shown that this NE scoring system 
has a high predictive value in neurodevelopmental outcome.  In a study published in 2017, it 
was shown that the Thompson score and the use of amplitude-integrated 
electroencephalography (aEEG) are similar in predicting developmental outcome.  It was 
concluded that both these methods may be used in the selection of neonates with NE for 
therapeutic cooling (Weeke et al., 2017; Bhagwani et al., 2016: 16-18; Thompson et al., 
1997: 757, 760-761). 
The Fenichel classification of NE is shown below, for comparison. This score was used 
previously at MMH, and was thus used to identify cases for the previous Kalume Kalunga 
study (Kalume Kalungula, 2008: 5,9-10, 21). 
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Table 3: Fenichel’s classification of severity of NE 
Grade 1 
(mild) 
Grade 11 
(moderate) 
Grade 111 
(severe) 
Irritability ‘hyperalert’  lethargic Comatose 
Mild hypotonia Seizures ; marked 
abnormalities of tone 
Prolonged seizures; severe 
hypotonia 
Poor sucking Require tube feeding Failure to maintain 
spontaneous respiration 
Fenichel JM. (1983) as quoted by Kalume Kalangula, 2008: 9-10). 
In 2016, at MMH, the criteria used for identification of NE infants was based on Shankaran 
NE categories and signs  (Table 4); Sarnat scoring and the Thompson score were used for 
assessing severity and monitoring progress (MMH, 2016). 
Table 4:  Shankaran NE categories and signs 
Category Moderate encephalopathy Severe encephalopathy 
Level of consciousness Lethargic Obtunded/stuporous/coma 
Spontaneous activity Decreased spontaneous 
activity 
No spontaneous activity 
Muscle tone Hypotonia Flaccid (profound 
hypotonia) 
Posture Distal flexion or extensor 
posture 
Decerebrate 
Suck or Moro (worst) Weak suck or partial Moro Absent 
Autonomic nervous system 
                         Pupils 
 
Heart rate 
 
respiration 
 
Miosis (fixed pinpoint) 
 
Bradycardia 
(<100beats/min) 
Periodic or shallow 
breathing/gasping 
 
Fixed dilated, slow, absent, 
unequal/deviated 
- 
 
Apnoea requiring IPPV 
Shankaran, 2005: 1575). 
At MMH in 2016, strict criteria were used for the diagnosis of NE. 
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    “ Neonatal encephalopathy (was) defined by:   
• aEEG voltage suppression or seizures OR  
• clinical seizures or dystonic movements OR  
• clinical signs of moderate to severe HIE (by Shankaran defined as abnormal          
signs in at least 3 categories). 
• depressed level of consciousness plus abnormal tone. ” 
 
(MMH, 2016). 
 
2.8   IMPLICATIONS OF NE 
 
2.8.1   Complications and sequelae of NE 
60% of babies with moderate or severe NE either die or have severe long- term impediment 
as shown in a study in India (Gane et al., 2013: 119).  CP may be an important consequence 
of NE; affected children may have a host of complications including gastrointestinal 
pathology, nutritional and feeding problems, recurrent aspiration pneumonia, orthopaedic 
problems, epilepsy and may have a decreased life expectancy.  In other children with NE who 
do not have CP, cognitive difficulties may be apparent. These may include learning 
difficulties like poor reading, inability to do mathematics, poor memory, language and 
communication skills (Eunson P, 2015: 48-49). 
2.8.2 Therapeutic cooling 
It has been shown that neonates with moderate or severe NE benefit from therapeutic 
hypothermia to decrease the risk of death and neurological insults at 18 months of age (Horn 
et al, 2013: e378; Edwards A. et al., 2010: e363).  At MMH, the strict criteria used in 
diagnosis of NE are used for brain cooling, as shown in section 2.7.  Neonates must be less 
than six hours old at the start of cooling.   
All infants requiring cooling need to be admitted to the NICU.  Timeous and careful 
assessment of neonates needs to be done to determine the risk of developing moderate to 
severe NE.  The sooner babies are diagnosed with NE, the sooner cooling can be commenced 
with resultant better outcome.   
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Neurological monitoring must be done whilst therapeutic hypothermia is being administered.  
This is done by clinical examination using the Thompson NE score and the Sarnat score 
(Sarnat (1976) quoted by MMH NE guideline, 2016). 
2.8.3 Social and financial burden 
The percentage of NE in developing countries associated with evidence of hypoxic and 
ischaemia in the intrapartum period is double (60%) that of the cases of NE in developed 
countries (30%).  This places an added burden on health care services, education and social 
services, to name but a few, and on already struggling and poverty-stricken countries. 
Furthermore, the family of a child with sequelae of NE have countless stresses e.g. they need 
someone to care for the child fulltime and often one parent needs to stay home to do so, with 
resultant decrease in family income.  This, in turn, may negatively affect the quality of life of 
siblings.  In addition, adults with neurological deficits may not be able to drive, may not have 
employment and may not be able to have meaningful relationships within society.  Thus, to 
reiterate, there is a need for specialised child and adult care, specialised education and 
specialised housing which means an increase on the financial burden for both the family and 
government services (Eunson, 2015: 48-50). 
2.8.4  Medico-legal implications 
As discussed above, NE has serious long-term sequelae including death, CP, low cognition 
and poor neurodevelopmental attainment.  As a result, the long-term cost of education and 
health care, etc. to parents is great.  This may lead to medical litigation.  In recent years, 
clinicians have been sued for sums exceeding 20 million rand, medical insurance for private 
specialists is exorbitant, and thus many have left the practise of obstetrics.  If one highlights 
just one consequence, e.g. CP, there are many causal pathways and even if an intrapartum 
cause is disproved in court, it still subjects the clinician to legal and professional stress 
(Johnson, Blair & Stanley, 2011: 97-98; Kurinczuk, White-Koning & Badawi, 2010: 329). 
 
2.9    FUTURE RESEARCH 
It would be of interest to do a follow-up case-control study of the Kalume-Kalungula NE 
study of 2008 to determine whether the NE incidence, associated obstetric factors and 
obstetric management have changed or improved over the years.  Further, a prospective study 
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to determine the long-term outcome of neonates diagnosed with NE at MMH will be 
compelling. 
 
2.10 CONCLUSION 
In conclusion, NE is an important condition affecting the neonate, mother and family, health 
services and society.  This study sets out to identify the obstetric factors in neonates with NE 
and possible avoidable factors at MMH, a busy level 2 hospital in Cape Town, South Africa.  
In doing so, we may be able to improve obstetric practices which may, in turn, decrease the 
incidence of NE in our setting. 
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3.   AIMS AND OBJECTIVES 
3.1 AIMS 
This research aims to demonstrate the obstetric factors occurring in patients who delivered 
neonates who were diagnosed with NE and to determine the avoidable factors, as used in 
PPIP, at MMH in 2016. 
 
3.2 OBJECTIVES 
1. To determine the NE rate at MMH  
2. To describe the obstetric factors in neonates who have NE  
3. To assess the avoidable factors present in the obstetric management of the patients who 
have neonates with NE 
4. To assess the avoidable factors related to patient and administrative factors in patients who 
have neonates with NE 
5. To compare the results of this study with those of international and other national studies, 
particularly to the previous MMH study done in 2008 
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4.  METHODOLOGY 
 
4.1   STUDY DESIGN 
A descriptive quantitative study design was used.  It was retrospective in nature and 
described the obstetric factors occurring in patients whose neonates were diagnosed with NE 
over a specific time period, January to December 2016. 
 
4.2   STUDY SETTING 
MMH is a government hospital.  It is one of the two regional hospitals in the Metropole West 
District, in Cape Town, SA.  In this district there is one tertiary hospital, Groote Schuur 
Hospital (GSH), six MOUs and three district hospitals.  Five MOUs (Guguletu, Hanover 
Park, Retreat, Mitchell’s Plain and False Bay hospital MOU) and one district hospital 
(Mitchells Plain Hospital) refer patients requiring district or regional level of care to MMH.  
Furthermore, the MOUs are staffed by midwives who manage low risk pregnant patients in 
the antenatal, intrapartum and postnatal periods.  If these patients become high risk, they are 
discussed with doctors at MMH for transfer.  The MOUs are governed by strict management 
protocols and referral criteria. In addition, MMH serves the local community of the suburbs, 
Mowbray, Rondebosch and Claremont.  MMH is an extremely busy hospital where there are 
approximately 10,000 deliveries per annum, with an average CS rate of 44% since 2010 
(PPIP, 2013).  
All neonates with NE in MMH’s satellite facilities are referred to and managed at MMH; and 
a large proportion would have delivered at MMH due to their mothers having been referred 
prior to delivery. 
 
4.3   STUDY POPULATION 
The study population included patients who delivered at MMH in 2016. The setting is 
characterised as low to middle income with poor socio-economic circumstances. 
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4.4   INCLUSION AND EXCLUSION CRITERIA 
4.4.1 Inclusion criteria  
The neonates who were diagnosed with NE, from mothers who delivered at MMH in 2016, 
were included.  They were identified by neonatal doctors, working at MMH.  The inclusion 
criteria were defined by the neonatal management protocol for NE used at MMH, described 
in section 2.7 (MMH, 2016).  They used a clinical management guideline which is based on 
Shankaran NE categories and signs, as described above.  NE was suspected if there were any 
clinical signs of encephalopathy and the presence of significant intrapartum hypoxia as 
evidenced by either a base deficit of 10 or more on cord blood or on neonatal blood within 
the first hour of life; or a five-minute Apgar score of less than seven and still requiring 
assisted ventilation at 10 minutes of life. A diagnostic aEEG is performed on these babies.  
Their mothers must have had a GA of more than or equal to 36 weeks, or they must have had 
a birth weight of more than and equal to 1.8 kilograms (kg), if GA was unknown.  NE is 
defined by voltage suppression on the aEEG or seizures; or clinical seizures or dystonia; or 
clinical signs of moderate to severe NE, as defined by Shankaran (2005: 1575); or decreased 
consciousness together with abnormal tone.  The names of the neonates with NE were 
obtained from a NE register which is kept by the neonatologists as part of their routine care. 
4.4.2 Exclusion criteria  
These were neonates that have not been identified with NE at MMH during the same study 
period, including those with severe congenital abnormalities, uncontrolled bleeding, 
uncontrolled systemic hypotension and uncontrolled persistent pulmonary hypertension, 
despite treatment. Neonates with NE who were born elsewhere were also excluded. 
                    
4.5   SAMPLE SIZE AND CALCULATION 
The sample size was a convenience sample, determined by the number of neonates diagnosed 
with NE who were born in 2016. The previous study in 2008 analysed one year’s data which 
included 38 cases of NE, and it was thought reasonable that this study should repeat a one 
year data collection period. 
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4.6   DATA COLLECTION 
All neonates who were diagnosed with NE were documented in an NE register in the 
neonatal unit.  Their names were collected from the register and each corresponding mother’s 
clinical notes was requested from the MMH Records Department.  The maternal folders of 
the cases were reviewed by the researcher by using an encephalopathy data collection tool 
that is used in Metropole West (see Appendix 4).  This was designed by a group of 
neonatologists and obstetricians who all gave input into what they thought was the essential 
data to collect in order to describe the obstetric factors found in neonates with NE in our 
setting.  It has not been validated, but is currently in use in Metro West.  The data collection 
tool is divided into different sections.  These include the pregnancy history, referring facility 
information (if applicable), transportation, labour, FHR monitoring during labour, staffing, 
delivery in labour ward (LW), delivery by CS and avoidable factors.  
The researcher reviewed the CTG recordings of each patient to assess whether they were 
normal, suspicious or pathological according to the NICE classification; and also whether the 
recordings were complete (NICE guidelines, 2017).  In cases where there was a difference in 
the researcher’s assessment and the attendant HCW’s documented assessment in the patient 
file; and /or when no written assessment of the recording was present, this was documented 
separately and noted as an avoidable factor. For example, the CTG interpretation found as 
normal or abnormal by the researcher, was what was described under the results section of 
the dissertation. In cases where the researcher assessed the CTG to be abnormal and this had 
not been noted or incorrectly assessed by the attendant HCW, this was noted as an avoidable 
factor.  
The length of time it took from ambulance dispatch to arrival at MMH, from CS decision to 
delivery and the duration of the first and second stage of labour were calculated by the 
researcher by looking at the time the clinical note entries were documented. 
The researcher also assessed the case notes for avoidable or modifiable factors, using the 
PPIP classification described in the Literature review. 
 
4.7   DATA ANALYSIS 
A statistician was consulted to assist with the analysis. Data was entered onto Microsoft excel 
2011 and STATA version 14 was used to analyse the data. Since the study was descriptive, 
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the data was presented as frequencies and percentages in tables.  Data was grouped into 
background demographic data; medical comorbidity; antenatal complications; gestational 
age, labour and delivery details and details of any required intrapartum referral. Avoidable 
factors, identified in the perinatal mortality and morbidity meeting where the cases were 
discussed, were also listed and classified into patient related, administrative related and 
medical personnel related. Descriptive statistics were used in analysing the data.  
 
4.8   POTENTIAL BIAS 
There were various elements that were anticipated to cause bias.  Firstly, MMH is a regional 
hospital which manages high-risk patients, thus the NE rate may be concentrated and 
potentially have a seemingly high incidence as the data was hospital-based and not 
population-based. However, this problem could be offset by using all deliveries in MMH plus 
satellite units as the denominator for calculating rates. Furthermore, the fact that data 
collection was retrospective and relied on entries in clinical notes, meant that if information 
had not been recorded or parts of the folders were missing, there would be incomplete data to 
enter.  
 
4.9   GENERALIZIBILITY                
The study was restricted to MMH because of the limiting factors of time and finance.  The 
study will address the issues relevant to the hospital, but the data may not be generalisable to 
the entire Metropole West District or other contexts. 
 
4.10 RELIABILITY AND VALIDITY 
The data collected was hoped to be reliable.  The data collection tool is being used at the 
coal-face in obstetric and neonatal practice and thus is practical and relevant.  
 
4.11 RISKS AND BENEFITS 
No patients were at risk as the study involved purely a folder review.  Since anonymity was 
maintained in the data collection process, analysis and final write-up, patients were further 
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protected from risk.  In conducting the study, there may be benefit for the institution (MMH) 
in that avoidable factors and preventative strategies may be identified.  Moreover, clinical 
management may improve which will, in turn, be of benefit to the patients and communities.  
 
4.12 ETHICAL CONSIDERATIONS 
Since the subjects were identified retrospectively and data retrieved from patient folders, 
individual patient consent was not required. The University of Cape Town (UCT) Human 
Research Ethics Committee gave permission (UCTHREC ref 122/2018, see Appendix 1) 
before the research commenced.  In addition, application for renewal of ethical approval was 
requested, see appendix 2. 
In addition, the Departmental Obstetrics and Gynaecology research committee of UCT 
approved the study and the MMH research committee gave permission to review the relevant 
folders on the premises.   
Anonymity and privacy were maintained.  However, in the initial identification of the cases, 
the mothers’ names had to be matched to each of them.  Once this was done, all data 
collected was recorded in code.  Furthermore, the data was stored on a password-protected 
computer and raw data and maternal folders were kept in a locked cupboard in a private, 
locked office.  Thus, only the researcher had access to the data. 
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5.  RESULTS 
5.1  INCIDENCE OF NEONATAL ENCEPHALOPATHY (NE). 
The number of MMH born neonates diagnosed with NE in 2016 at MMH was 57, as per the 
NE register.  Five obstetric folders could not be retrieved, and 4 patients had a GA of less 
than 36 weeks, on folder review, see figure 1. Thus, 48 folders were audited and analysed.   
Figure 1.  Identification of cases 
    
 
 
 
       
 
 
 
 
         
 
 
 
             
 
 
 
 
      57 cases in neonatal register 
 
              4 had GA < 36 weeks 
                 (thus excluded) 
 
        5 folders could not be found 
 
         Total of 48 folders analysed 
35 
 
The total number of live births at MMH in 2016 was 9,702; and at MMH plus the MOUs 
which refer to it, was 17,751.  The NE rate was thus calculated to be 5.5 per 1000 live births 
(LB) for MMH, and 3.0 for MMH and MOUs combined. 
 
5.2  PATIENT DEMOGRAPHICS 
The demographics of the patients included in the study are demonstrated in Table 5.   
 
Table 5:  Patient demographics   N=48 
Characteristics Mean (range), Median (range) or n (%N) 
Mean Age in years (range)  27.5 (15-40) 
Age < 20yrs 10 (20.8%) 
Parity = 0 24 (50%) 
Median parity (range) 0.5 (0-5) 
Booked for antenatal care  48 (100%)  
Miscellaneous maternal medical condition 4 (8.3%) 
BMI> 35 kg/m² 14 (29.2%) 
Previous Caesarean Section 6 (12.5%) 
Smoking history 9 (18.8%) 
HIV positive 8 (16.7%) 
VDRL positive  0 
Drug/alcohol use 5 (10.4%) 
 
There was a total of 48 patients, their age group ranged from 15 to 40 years with a mean of 
27.5 years; and their parity from nought to five with a median of 0.5.  There were 10 patients 
less than 20 years of age, and 24 (50%) who were nulliparous.  There were 14 (29.2%) 
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patients who had a body mass index (BMI) of 35 and greater.  All 48 patients had been 
booked for antenatal care. Of the 48 patients, 12.5% had had previous Caesarean Sections, 
16.7% were human immune-deficiency virus (HIV) positive and none had syphilis. Four 
patients had miscellaneous medical conditions, namely, hepatitis B, chicken pox, urinary 
retention and previous back surgery. A history of smoking was obtained in 18.8%, and 10.4% 
used drugs or alcohol. 
 
5.3  COMPLICATIONS IN THE ANTENATAL PERIOD 
Complications in the antenatal period are shown in Table 6.   
 
Table 6: Antenatal complications  N=48 
Complications Number (%) 
Nil  11 (22.9%)  
Antepartum Haemorrhage (APH) 4 (8.3%)  
Hypertensive disorder 9 (18.8%) 
Maternal infection  1 (2.1%)  
Prelabour PROM >18 hours 4 (8.3%)  
GDM*/ IGT* 0 
Suspected IUGR 1 (2.1%) 
Abnormal FHR (not in labour) 3 (6.3%)  
Multiple pregnancy 3 (6.3%) 
Prolonged pregnancy 12 (25%) 
*GDM – Gestational diabetes mellitus; *IGT – Impaired glucose tolerance 
Antenatal complications were found in 37 (77.1%) patients. They ranged from one (2.7%) 
patient with a growth restricted (IUGR) fetus to 12 (25%) patients with prolonged pregnancy. 
Prolonged pregnancy was defined as more than or equal to 41 weeks gestation.  The 
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gestational age of five (41.7%) of the 12 patients were determined by early ultrasound scan, 
three (25%) each by last normal menstrual period and booking palpation and one (8.3%) by 
late ultrasound scan.  Nine (18.8%) patients had hypertensive disorders, of which six had pre-
eclampsia (PET), two had gestational hypertension and one had chronic hypertension. There 
were 4 (8.3%) patients with prelabour PROM of more than 18, but less than 24 hours; but no 
patients with PROM more than 24 hours.  Four had APH, three patients had an abnormal 
FHR detected by auscultation and three had multiple pregnancies.  Of note, there were no 
diabetic patients with GDM or IGT.  There was one patient with a maternal infection which 
was chicken pox. There were 11 (22.9%) patients who had no antenatal complications. 
No patients had antenatally diagnosed congenital abnormalities, however, there were three 
patients who never had an ultrasound scan.  None of the patients had had abdominal trauma 
in their pregnancy. 
 
5.4  ONSET OF LABOUR 
Table 7:  Onset of labour details N=48 
Characteristics Mean  (range), or  number (%N) 
Mean GA at onset of labour or delivery (weeks) 39 (36-45) 
Delivered by CS before labour onset  6 (12.5%)  
Spontaneous labour 35 (72.9%) 
Induction of labour 7 (14.6%) 
Table 7 shows that six (12.5%) patients were delivered by CS before labour onset, four were 
for pathological CTGs, one for eclampsia and one for previous Caesarean for abruptio 
placentae.  There were 42 patients (87.5%) who underwent labour; 35 (72.9%) patients had 
spontaneous labour, and seven (14.6%) patients were induced.  The mean GA at onset of 
labour or delivery was 39 weeks. 
There were seven patients who had induction of labour (IOL) for which five received 
misoprostol alone, and two had a combination of misoprostol and AROM.  All IOLs were 
started at MMH.  There were two IOLs for hypertensive disorders, and one due to a previous 
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SB, twins at 37 weeks, prolonged pregnancy and urinary retention, respectively.  It was not 
clear why one of the seven patients had an IOL. 
There were 35 patients who commenced labour spontaneously; 15 (42.9% of 35) were 
admitted directly to MMH in labour, whereas 20 (57.1% of 35) were initially admitted to an 
MOU and then referred to MMH. 
 
5.5  LABOUR DETAILS           (N=42) 
Labour details are divided into maternal (Table 8) and fetal care (Table 9a and 9b) aspects.  
Table 8 indicates the details of labour for the 42 patients who were in labour.  The mean 
length of the first stage of labour (latent and active phase together) was 10 hours (597 
minutes), and 17.9% had a prolonged first stage. Prolonged first stage was defined as greater 
than 18 hours, reflecting a latent phase of  >12hrs and an active phase of  > 6hours in keeping 
with SA national guidelines. In the data collection sheet, latent and active phases were not 
distinguished. The mean length of the second phase of the second stage of labour was 39 
minutes, and for 25% the second phase was prolonged (greater than 60 mins). The length of 
Second stage of labour was measured from the onset of active pushing (‘bearing down’) 
efforts; and the definition of a prolonged second stage of .60 mins used for both primigravida 
and multigravida.  Three patients were given an oxytocin infusion for aungmentation, 12 
(28.6%) had more than 4 vaginal examinations.   
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Table 8:  Maternal care aspects (N=42) 
Characteristics Mean (range); number (percentage) 
Mean length of first stage (minutes) 597.0 (75-3445) 
Prolonged first stage (>18hours) 7 (17.9% of 39) * 
Mean length of second phase of second 
stage (minutes)  
39 (2-103) 
Prolonged second phase of second stage of 
labour (>60min) 
6 (25% of 24)**  
Temperature > 37 degrees C 2 (4.2% of 48) 
Multiple PV exams (> 4)  12 (28.6% of 42) 
Oxytocin infusion 3 (7.1% of 42)  
Partogram usage in MOU labour referrals 15 (75% of 20)*** 
*Information lacking for 3 patients 
**24 patients had a second stage of labour (24 had CS before second stage)                                                                                   
*** 20 patients in labour from the MOU 
Information on use of the partogram was collected for the MOU patients who were 
transferred in labour, but not for the patients who commenced labour at MMH.  It was noted 
that 15 of the 20 (75%) MOU  in all patients in labour, two had temperatures more than 37 
degrees Celsius. 
The methods of FHR monitoring at the MOU and MMH are shown in Table 9a; and the 
results of fetal monitoring / assessment shown in Table 9b. 
Table 9a:  Methods of fetal heart rate monitoring   
Method MOU patients (n= 20) (%) MMH patients (n=48)*(%) 
IA 17 (85%)        0 
CTG 3 (15%)      46 (95.8%) 
IA and CTG 0 2 (4.2%) 
*includes patients referred from MOU 
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5.5.1  FHR monitoring of labouring patients at the MOUs 
 
Intermittent auscultation (IA) by Pinard stethoscope or Doptone (hand-held sonographic 
device) was used in 85% (17 of 20) of patients in labour at the MOUs.  
There were 20 patients in latent labour at the MOUs of which 11 (55%) had FHR monitoring 
two hourly, in accordance with protocol, while in six (30%) patients IA was not done 
adequately (this is also referred to under Avoidable factors, Table 14).  Three (15%) patients 
had CTG monitoring at the one MOU which has a CTG machine. Two of the three patients 
went on to have CTG monitoring in active labour and one was transferred to MMH before the 
active phase of labour. 
 There were eight patients in the active phase of labour at the MOUs, only one (12.5% of 8) 
had the FHR monitored every 30 minutes in accordance with protocol, while five (62.5% of 
8) had inadequate monitoring (this also referred to under avoidable factors, Table 14).  Two 
(25% of 8) had CTGs.  There were no patients who had a combination of IA and CTG use. 
All eight patients in active labour at the MOUs presented to the MOUs in latent labour. 
Summarising method and quality of fetal heart monitoring at MOUs; all 20 patients who were 
admitted in spontaneous labour at an MOU were in the latent phase and all had fetal heart 
monitoring, the majority by IA. In 70% of patients in the latent phase of labour it was fully 
documented and according to protocol, but in 30% it was incomplete / not documented.  In 
the active phase of labour, 37.5% had FHR monitoring fully documented and in 62.5%, 
documentation was incomplete. 
Of the 28 women referred from MOUs to MMH, 10 patients had an abnormal FHR detected 
at the MOU; two had fetal bradycardia, two had fetal tachycardia and six were termed ‘fetal 
distress’.   
5.5.2  FHR monitoring of patients in labour at MMH  
All 48 patients (including those referred from MOUs) had CTG monitoring at MMH. This 
included the 42 women in labour and the 6 who had a CS before labour.                                                                                            
Considering timing of commencement of monitoring for all 48 patients after admission, 
CTGs were started immediately upon arrival in 19 (47.5%) of 40 patients for whom there was 
documentation of the time of commencing a CTG. In 23 (57.5% of 40) patients the CTG was 
started any time from nine to 80 minutes after admission at MMH, with a mean time of 17 
minutes.  There were six (12.5% of 48) patients who had no documentation of the time the 
CTG was first started on arrival. There was a poor quality CTG trace in 10 (20.8% of 48) 
patients where there were many places on the CTG with loss of contact. 
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Considering the 42 patients in labour at MMH (which includes the 20 patients who were 
referred from the MOUs), CTG monitoring was used in all 42 (100%); in two patients IA was 
used in addition.  No patient had IA alone at MMH. All MMH CTGs were assessed by the 
researcher.  
The results of fetal assessment in labour are shown in Table 9b. Of the 42 CTGs, 10 could not 
be assessed due to poor quality. This meant that 32 CTGs were assessable (i.e. could be 
interpreted). Of these, one was normal and 31 were abnormal according to the researcher’s 
assessment.  
The researcher identified 29 (90.6%) of the 32 assessable CTGs (prior to delivery) as being 
pathological whilst two (6.3%) were suspicious according to the NICE guideline 
classification. Of note, the researcher’s assessment coincided with the attending HCW in all 
assessable cases, except for 11, where the abnormality was not recognised by the HCW, 
either because the CTG was not reviewed  (seven cases) or it was interpreted incorrectly (four 
cases).  This is referred to in section 5.10 on HCW avoidable factors.  
Of the 31 patients with an abnormal FH, 27 (87.1%) of them received intrapartum 
resuscitation. This included intravenous fluids, left lateral position and tocolysis with 
salbutamol. 
 
Table 9b: Fetal assessment in labour at MMH  (N=42) 
Characteristics Number (percentage) 
Abnormal FH – pathological 
- suspicious 
29 (90.6%) of 32 assessable CTG)* 
2 (6.3% of 32)  
Normal FH 1 (3.1% of 32) 
Meconium stained liquor (MSL) 17 (40.5% of 42) 
Intrapartum resuscitation 27 (87.1%  of 31 with abnormal CTG) 
*10 CTGs were poor quality and could not be assessed, leaving 32 which were ‘assessable’  and where an 
interpretation could be made 
There were 40.5% of labouring patients with MSL.   
Eight of 10 (80%) patients who had an abnormal FHR detected by intermittent auscultation at 
the MOUs prior to referral, had abnormal CTGs at MMH, one had a normal CTG at MMH 
and the other had no documentation of the FHR just before delivery. 
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5.6  MOU REFERRALS  
Table 10 details the referrals from the MOUs.  The total number of patients that were referred 
was 28, 58.3% of the patients included in the study. Twenty were intrapartum referrals, and 8 
were not in labour. Some patients had more than one reason for being transferred, hence the 
number in the table does not add to 28.  Five (17.9%) patients had prolonged first stage of 
labour.  One (3.6%) was transferred for prolonged second stage of labour, two (7.1%) with 
MSL and 10 (35.7%) with an abnormal FHR.  There were six (21.4%) referred with 
hypertensive disorders and two with prolonged pregnancies.  The three miscellaneous reasons 
include maternal hepatitis B disease, a patient with a previous back operation and one with 
proteinuria only.  Of the eight patients who were not in labour upon transfer, there were  four 
with pre-eclampsia, two with prolonged pregnancy, one with APH and fetal bradycardia and 
one with fetal distress.   
 
Table 10:  Referrals from MOUs  N=28 
Reason Number (percentage) 
Prolonged first stage of labour 5 (17.9% of 28)  
Prolonged second stage 1 (3.6% of 28) 
MSL 2 (7.1% of 28) 
Abnormal FHR 10 (35.7% 28) 
Hypertensive disorders 6 (21.4% of 28) 
Prolonged pregnancy 2 (7.1% of 28) 
APH 1 (3.6% of 28) 
Miscellaneous 3 (10.7% of 28) 
 
Of the 10 patients who had an abnormal FHR, two had fetal bradycardia, two had fetal 
tachycardia and six were termed ‘fetal distress’.  The patient who had a prolonged second 
stage of labour, was referred from a midwife who was managing a patient with a low risk 
pregnancy and labour at home.  She resided in the MMH drainage area and was subsequently 
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managed in MMH’s labour ward; the midwife called for doctor’s assistance 50 minutes after 
bearing down efforts began. 
Referral times for MOU Referrals 
 
The time it took from when the MOU midwife booked the ambulance to when it was 
dispatched ranged from one to 102 minutes (min) (2 hours 42 min).  The time the ambulance 
took from dispatch to arrival at MMH, after collection of patient from the MOU, ranged from 
27 to 191 min (3 hours and 11 min).  The mean time was 66 min (1 hour and 6 min).  The 
mean time of the overall transfer decision to arrival at MMH was 104 min (1 hour and 44 
min) and ranged from 34 to 230 (3 hours 50 min) min.  There was no documentation of either 
booking time or arrival time in three patients. 
 
5.7  MODE OF DELIVERY 
Table 11: Mode of delivery  N=48 
Mode of delivery Number (percentage) 
Normal Vaginal Delivery (NVD) 12 (25%)  
Breech delivery 1 (2.1%) 
Caesarean section 28 (58.3%)  
Vacuum extraction 6 (12.5%) 
Forceps delivery 1 (2.1%) 
 
Table 11 describes the mode of delivery for all 48 patients.  There were 12 normal vertex 
deliveries (NVD) (27.1%), one (2.1%) vaginal breech and 28 (58.3%) CS. Assisted deliveries 
(six vacuums and one forceps) accounted for 14.6% of deliveries. There were eight attempted 
vacuum deliveries, two of which failed.  Of the failed vacuum attempts, one ended up as a 
NVD and one as a forceps delivery.  There were two forceps attempted in total, one was 
successful (one of the failed vacuum attempts), the other failed and ended up as a CS. 
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The indications for the assisted deliveries were all pathological CTG, except one which was 
done for prolonged second stage of labour.  In all the assisted deliveries the prerequisites 
were met.  
There was one vaginal breech delivery, this was the second twin of one of the patients with 
multiple pregnancy. 
There were three sets of twins.  One patient had NVDs for both twins, the other two patients 
required a CS each for the second twin, due to them having pathological CTGs.  
 
5.8  CAESAREAN SECTION INDICATIONS 
Table 12 describes the indications for the 28 CS which includes the six patients who had CS 
before labour and were described in the text following Table 7.   
Table 12:  Indication for Caesarean Section N=28 
Indication Number (percentage)) 
Prolonged first stage of labour 0 
Prolonged second stage of labour 2 (7.1% of 28) 
Suspected abruptio placentae 3 (10.7%) 
Cord prolapse 1 (3.6%) 
Failed assisted delivery 1 (3.6%) 
Eclampsia 1 (3.6%) 
Pathological CTG 20 (71.4%)  
 
The majority of the CS (71.4%) were for pathological CTG.  Two of the CS done for 
pathological CTG were for a second twin. There were three (10.7%) CS done for suspected 
abruptio placentae, two (7.1%) for prolonged second stage of labour and one (3.6%) each for 
cord prolapse, failed assisted (forceps) delivery and eclampsia.   
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5.9  SENTINEL EVENTS 
Sentinel events refer to major obstetric complications known to be causally associated with 
NE. There were 15 patients with recognised sentinel events and 33 without. One patient had 2 
sentinel events.  Table 13a refers to the timing of the SE, while Table 13b details the different 
types of SE that occurred.  
As seen in Table 13a there were 4 patients with antenatal sentinel events. These included one 
patient with eclampsia (2.1% of 48), and three with abruptio placentae (6.3% of 48). 
 
Table 13a:  Number of patients who had a sentinel event for NE; and the timing. N=48 
Period Number of patients 
Antepartum 4 
Intrapartum 11 
No documented sentinel event 33 
 
Intrapartum sentinel events included 5 patients with prolonged second stage of labour (10.4% 
of 48), one with cord prolapse (2.1% of 48) and five with shoulder dystocia (10.4% of 48). 
Four of the patients who had prolonged second stage of labour were high risk patients who 
started the second stage at MMH LW. The fifth patient who had a prolonged second stage of 
labour was initially a low risk, local patient managed by a midwife in labour at home.  Three 
of the patients with prolonged second stage of labour had a vacuum delivery, and two needed 
a CS. 
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Table 13b:  Type of sentinel events N=15 
Type Number (percentage) 
Abruptio placentae 3 (6.3% of 48) 
Eclampsia 1 (2.1%) 
Prolonged second stage of labour 5 (10.4%)  
Shoulder dystocia 5 (10.4%) 
Cord prolapse 1 (2.1%) 
No sentinel event 33 (68.8%) 
 
Of the five patients who had shoulder dystocia, all the patients had a BMI of less than 
35kg/m2.  The neonates’ birth weights were 4005g, 3880g, 3820g, 3635g and 3600g 
respectively. 
There were 33 patients with no documented sentinel event. Twenty-five (75.8%) of them had 
pathological CTGs, with no obvious obstetric reason. 
 
5.10  AVOIDABLE FACTORS 
The avoidable factors are demonstrated in Table 14.  
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Table 14:  Assessment of avoidable factors / substandard care  N=48 
Avoidable factors Number (percentage) 
Patient-related:  
Infrequent ANC visits 1 (2.1% of 48) 
Administrative-related:  
Transport delay 12 (42.9% of 28 transfers) 
Delay in access to theatre (theatre 
occupied) 
7 (25% of 28 CS) 
Delay in access to theatre (no reason 
documented) 
8 (28.6% of 28 CS) 
Medical personnel-related:  
Delay in referral 1 (3.6% of 28 referrals) 
Inadequate FHR monitoring at MOU 
     in latent phase  
     in active labour 
 
6 (30% of 20 in latent labour at MOU) 
5 (62.5% of 8 in active labour at MOU) 
MMH:  
Poor quality CTG tracing  and monitoring 
Fetal distress not detected in labour, 
despite fetal monitoring *  
 
10 (20.8% of 48) 
11 (34.4% of 32 assessable traces in labour) 
Delay in doctor’s assessment on patient 
arrival (>60min) 
10 (20.8% of 48) 
Anaesthetic delay 1(3.6% of 28) 
*This included CTG not being reviewed (7 cases) or CTG misinterpreted (4 cases) 
Avoidable factors were sub-divided into patient related, administration related and medical 
personnel related, in accordance with the classification used by the Perinatal Problem 
Identification  Programme (PPIP).  
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5.10.1  Patient related avoidable factors 
There was one (2.1%) avoidable factor which was patient related, this was infrequent 
antenatal visits. 
 
5.10.2  Administrative related avoidable factors 
For twelve (42.9%) of the patients transferred to MMH, there was a transport delay 
(ambulance dispatch time to MMH arrival time of more than 60 min).  There were 15 patients 
(53.6% of those having CS) who had a delay in performing emergency CS of more than one 
hour from the decision to do it.  For seven (25%) theatres were occupied with other 
emergencies, and in eight (28.6%) there was no documentation of the reason for the delay. 
 
5.10.3  Medical personnel related avoidable factors 
There was one (3.6% of 28) patient where the decision to refer from an MOU was delayed. 
At the MOUs, there were six (30% of 20) who had inadequate FHR monitoring in latent 
phase and five (62.5% of 8) who had inadequate FHR monitoring in the active phase of 
labour. 
At MMH, in 34.4% of the 32 assessable CTGs in labour, fetal distress was not detected even 
though the fetus was monitored.                                                                                              
There was a delay in a doctor assessing the patients upon arrival in 10 cases (20.8% of 48).  
In one patient requiring emergency CS, surgery was delayed due to an anaesthetic difficulty 
with inserting an intravenous line and performing spinal anaesthesia. 
 
5.10.4  Birth time and Shift handover 
The nursing staff work 12 hour shifts i.e. 7am to 7pm on day shift and 7pm to 7am on night 
shift.  We looked at how many neonates were born during the shift handover period (6am to 
8am and 6pm to 8pm).  Five (10.4%) neonates were born at this time in the morning (end of 
night shift) and three (6.3%) at night (end of day shift). Together this constituted 8 (16.7%) of 
the study group. 
 
5.11  NEONATAL CHARACTERISTICS 
These are shown in Table 15.  
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Table 15:  Neonatal characteristics N=48 
Characteristics Frequency (%) 
Maximum NE score*:  
Mild (1-10) 29 (76.3% of 38)  
Moderate (11-14) 4 (10.5% of 38) 
Severe (15+) 5 (13.2% of 38) 
Gender:  
Female 17 (35.4%) 
Male 31 (64.6%) 
Birthweight**:  
Less than 2000g 1 (2.1% of 47) 
2000-2499g 3 (6.4% of 47) 
2500-3499g 29 (61.7% of 47) 
More than 3500g 14 (29.8% of 47) 
Apgar score***:  
1 min Apgar less than 4 28 (59.6% of 47) 
5 min Apgar less than 7 27 (57.4% of 47) 
10 min Apgar less than 7 8 (34.8% of 23) 
*NE score not documented in 10 neonates 
** BW not documented in one neonate 
*** Apgar scores not done for all neonates 
 
5.11.1  Maximum Thompson NE score 
The maximum Thompson NE score refers to the highest score recorded for the neonate 
during the hospital stay; and this was recorded in the neonatal NE book for 38 of the 48 
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(79.2%) neonates. There were 76.3% of neonates with a maximum NE score ranging from 1 
to 10 (mild).  There were 4 (10.5%) with moderate NE (11 to 14) and 5 (13.2%) of neonates 
had severe NE (15 and above).  
 
5.11.2  Gender 
There were 64.6% of the neonates who were male and 35.4% were female. 
 
5.11.3  Birthweight 
Most (61.7%) neonates weighed between 2500g and 3499g.  There was one who weighed 
less than 2000g and 29.8% weighed more than 3500g. 
 
5.11.4  Apgar score 
The one and five minute Apgar scores were recorded in all neonates except one; while 23 
neonates had a 10 min Apgar score recorded. 59.6% of the neonates had a one min Apgar 
score of less than four, 57.4% had a score of less than seven at five min and 34.8% had an 
Apgar score of less than seven at 10 min.   
 
5.12. MAXIMUM NE SCORE AND SENTINEL EVENTS 
A sub analysis was performed comparing the maximum NE score in patients with and 
without sentinel events. This is shown in Table 16  
Table 16. Maximum NE score and occurrence of sentinel events (N=38) 
Sentinel event Max NE <=10 Max NE >10 Total 
Nil 17 (68%) 8 (32%) 25 (100%) 
Occurred  12 (92.31%) 1 (7.69%) 13 (100%) 
Total  29 (76.32%) 9 (23.68%) 38 (100%) 
Pearsons chi2 = 2.7959; p=0.095 
There was a higher proportion (32%) of severe NE outcomes in patients with no sentinel 
events compared to those having a sentinel event (7.69%). However, there was no significant 
association between the occurrence of sentinel events and the maximum NE score. 
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6. DISCUSSION 
A summary of the results of our study is discussed in this chapter.  These findings will be 
compared to findings of other studies which were done in our local and national setting and in 
an international context. 
 
6.1  INCIDENCE 
The incidence of NE at MMH, and MMH together with the MOUs referring to it, was 
determined.  The NE rate was 5.5 per 1000 LB for MMH in 2016, and 3.0 per 1000 LB at 
MMH when including live births from its catchment area in the denominator. The NE rate at 
MMH of 5.5 in this study has shown an increase compared to the 2008 MMH study done by 
Kalume Kalangula when it was 3.7 per 1000 live births.  In 2016 there were 9,702 LB at 
MMH which is 540 (5.6%) higher than the number of live births in 2008 (9,162). The 
increase may well be due to increased identification of mild NE cases, with the strict use of 
the Shankaran criteria in the NE protocol, which was not used in 2008.  It may also be as a 
result of an increase in workload, with more referrals from MOUs, which places an added 
burden to an already busy maternity hospital with limited resources.  Furthermore, it may be 
due to a shift from mortality to morbidity. When we look at the perinatal mortality rate 
(PNMR), as measured in annual PPIP statistics, for neonates with birth weights of over 2500g 
in 2008 and 2016, it is clear that the PNMR for MMH in 2008 was higher with a rate of 
7.5/1000 deliveries compared to that of 2.9/1000 deliveries in 2016. In addition, for the 
hypoxic neonatal deaths there is a slight difference in the proportion between the two years.  
In 2008, 71.4% (10 neonates) of all babies who died weighing more than and equal to 2500g 
had hypoxic deaths, whereas for 2016 it was 66.7% (four neonates). This may suggest that 
the higher NE rate in 2016 may be, in part, due to earlier HCW intervention which prevents 
fresh stillbirths from hypoxia.  This would be consistent with the higher CS rate in our study 
compared to 2008, which is discussed more in section 6.8 (PPIP, 2013).  Another reason for 
the increase in NE rate may relate to case identification. In the previous study the cases were 
identified by using the Fenichel criteria (1983) quoted by Kalume Kalangula, 2008: 5,9-10, 
21). 
The NE rate of 5.5 per 1000 LB is comparable to the hospital-based study by Itoo et al in 
Saudi Arabia which was 4.7 per 1000 LB.  This falls in the range of NE rates (1.0 to 8.0) seen 
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from different studies done worldwide (Kurinczuk, White-Koning & Badawi, 2010: 330, 
332). 
It is difficult to determine the incidence of NE globally as some studies are hospital based and 
others population based.  Also, different obstetric units and different countries may use 
different definitions of NE. It is not surprising that the NE rate in hospital-based studies are 
higher than the population based studies.  This is due to the fact that high risk patients (who 
may have more risk factors) are referred to hospital.  Hospital based international studies 
done in the past include, amongst others, the Saudi Arabia study as discussed earlier and the 
study done in Nigeria which had a NE rate of 26.2 per 1000 LB, which is much higher than 
our rate (Kurinczuk White-Koning & Badawi, 2010: 330, 332).  Closer to home, a 2015 
published study which was done at a large hospital in SA, CHBAH, had a NE rate of 8.7 per 
1000 LB (as defined by need for bag mask ventilation at birth, Apgar score < 7 at five 
minutes and a base deficit > 12 mmol/L)  which is also higher than our rate (Bruckmann & 
Velaphi, 2015: 299). Moreover, it was shown that in developing countries HIE constitutes 
60% of NE cases, whereas in developed countries 30% of the NE cases are due to HIE 
(Kurinczuk, White-Koning & Badawi, 2010: 337). 
 
6.2  PATIENT DEMOGRAPHICS 
The descriptive study design, with no control group, did not allow an assessment of 
demographic risk factors for NE to be identified.  
The patient demographics which were interesting in the current study were age, parity, 
obesity, smoking history booked and HIV status. 
There were 10 patients (20.8% of 48) who were under the age of 20 years, this corroborates 
with the Gane et al. study done in India and the Martinez-Biarge et al. study done in the 
United Kingdom (UK).  They showed that patients under 20 years of age were at increased 
risk of having babies with NE.  In contrast, the previous MMH study showed that 38% of 
patients were under 20 years of age, nearly double that of our study.  
Nulliparity occurred in 50% of patients in our study which is greater than the prevalence of 
nulliparity in the pregnant population in SA. This is in keeping with the Gane et al. and 
Martinez-Biarge et al. studies which demonstrated nulliparity to be a significant risk factor 
for NE.  The previous 2008 MMH study showed that 65%  were nulliparous patients but this 
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did not differ significantly from controls, reflecting that  nullipara may be referred more in 
labour  from primary care than multipara.  Interestingly, primiparity had a low association 
with NE in the Nepal study (Gane et al., 2013: 120, 121; Martinez-Biarge et al., 2013: e954, 
e955; Kalume Kalangula, 2008: 23; Kurinczuk, White-Koning & Badawi, 2010: 335).   
All patients in our study were booked, similar to the previous study which had 97% booked 
patients.  This was a conflicting finding compared to the India, the West Australia and the 
Nepal study, respectively.  They found that being unbooked and not having adequate 
healthcare in pregnancy predisposed their patients to having babies with NE.  The 
Bruckmann & Velaphi study also had patients who had a high booking status, 95.6%, very 
similar to our 100%.  This is an interesting finding which poses the question of the adequacy 
of the antenatal care in SA as most patients had access to care, yet had babies with NE; or it 
shows that in our setting, intrapartum factors play a much bigger role in developing NE.  The 
latter is most likely.  We shall expand on this later in the discussion (Gane et al., 2013: 120, 
121; Kurinczuk, White-Koning & Badawi, 2010: 335; Bruckmann & Velaphi, 2015: 300). 
Nearly 30% of patients had a body mass index (BMI) of  >35.  However this is a similar 
prevalence to recent BMI studies in the general Cape Town pregnant population so is 
unlikely to have any significance.  
A smoking history was found in nearly 20% of patients.  One patient who smoked cigarettes 
was one of the three who had an abruptio placentae; smoking is known to predisposes 
patients to abruptio placentae.  Another smoker had a baby with a low birth weight (LBW) 
<2500g , one of four babies with LBW. 
HIV occurred in 16.7% of our patients this, however, was similar to the Western Cape (WC) 
Province prevalence rate of 12.6% (Kanabus, 2018). Our HIV positive rate was nearly half of 
that of the CHBAH, which was 25.9% (Bruckmann & Valaphi, 2015: 300), but very similar 
to the 18% of the previous MMH study (Kalume Kalangula, 2008: 23). 
 
6.3  ANTENATAL COMPLICATIONS 
An antenatal complication was present in the majority (77.1%) of patients in the current 
study.  This is in keeping with the previous 2008 study with 71% of cases having antenatal 
complications.  The most frequent complications included prolonged pregnancy (25%) and 
hypertensive disorders (18.8%).  Both of these are comparable to international studies.  The 
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West Australian study showed that the risk of babies having NE increased as the pregnancy 
lengthened.  In terms of hypertensive disorders, both our study and the 2011 Bruckmann & 
Velaphi study demonstrated similar proportions (18.8% and 19.6% respectively) of patients 
having babies with NE.  This is supported by the West Australia and the India study which 
both had pre-eclampsia as a major risk factor.  The Nepal study did not have an increase in 
NE observed in patients with hypertension.  Similarly, in the previous study, a low proportion 
(9%) of patients with pre-eclampsia had NE, this is about half that of our study (Kalume 
Kalangula, 2008: 24; Kurinczuk, White-Koning & Badawi, 2010: 335-336). 
APH in our study accounted for 8.3% of patients.  Both the West Australia and India studies 
displayed a significant relationship between APH and NE, while Bruckmann & Velaphi and 
the Nepal study did not look at APH as a factor.   
In addition, PROM played a role in NE as demonstrated in the current study (8.3%), the 
Nepal study and the India study (50% higher than controls). 
We had 6.3% of our patients with multiple pregnancy (twins).  This is higher than the 
incidence of twins in total  MMH deliveries, and could be in keeping with the Nepal study 
which showed that twin pregnancy was their greatest risk factor for NE.  In addition, The UK 
study also showed an increase in NE with twin pregnancies.  Surprisingly, the previous MMH 
study reported no twin pregnancy.   
Further, we had a low proportion (2.1%) of patients with infections in pregnancy and labour 
whereas the previous study had a higher proportion (12%); the West Australia study showed 
significant risk of NE in patients with infections (Kalume Kalangula, 2008: 24; Kurinczuk, 
White-Koning & Badawi, 2010: 335-336; Martinez-Biarge et al., 2013: e955). 
Of interest, we had no patients with IGT as a complication.  GDM and IGT were not factors 
considered in the studies mentioned above, except for the India study which showed an 
increase in DM in cases compared to controls, however, this was not statistically significant 
(Gane et al., 2013: 120). 
In summary, this section on antenatal complications can describe the frequencies of the 
various factors but cannot, like some of the other studies referred to, identify risk factors due 
to the lack of a comparison group. 
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6.4  ONSET OF LABOUR 
There were 87.5% (42) of patients in our study who were in labour, the vast majority (83.3%) 
of them were in spontaneous labour and 16.7% underwent IOL.  In the study done in Nepal, 
IOL was a significant risk factor for NE while that in West Australia was not.  However, the 
indications thereof in the former study were not studied and thus one can only postulate that 
the IOL indications were of such a nature to increase risk of NE.  Similarly, in our study just 
over half of the IOL patients had indications (prolonged pregnancy, hypertensive disorders 
and twins) which are known to have an increased association with NE.  These findings were 
in keeping with both the Martinez-Biage and the Gane studies (Kurinczuk, White-Koning & 
Badawi, 2010: 336; Martinez-Biarge et al., 2013: e995; Gane et al., 2013: 120). 
Furthermore, 20 patients (57.1%) of the 35 patients in spontaneous labour were initially 
admitted to the MOUs and were subsequently transferred to MMH.  Some of the reasons for 
transfer were slow progress in the first and second stage of labour, fetal distress and IUGR in 
labour.  Referral times and transport issues will be discussed further in section 6.7.  
 
6.5  MATERNAL CARE ASPECTS OF LABOUR 
There was a total of 42 patients in labour in our study, 17.9% of these had a prolonged first 
stage of labour (latent and active phase) and in 25% of the patients who reached the second 
stage of labour, the second phase of active bearing down, was prolonged.  This was much less 
than that found in the previous MMH study where 76% of the cases had prolonged first stage 
and 41% had prolonged second stage of labour.  The use of oxytocin was also far less (7.1%) 
in the current study than that (38%) in the previous study.  These findings are compelling as 
prolonged first and second stage of labour, particularly the latter, are known to have higher 
NE rates, however our study revealed a higher NE rate than the 2008 study despite having 
lower proportions of prolonged first and second stage of labour. 
Looking at PROM, the current study and the 2008 study both had about 8% of cases 
complicated by this.  The Nepal study showed that PROM was an important risk factor in 
NE, but this was not found in the West Australia study. 
Partogram usage was only recorded in our study for the MOU patients who were transferred 
in labour (20 patients).  It is unfortunate that this was not done for the patients known to 
MMH, thus we cannot comment and make adequate comparisons.  It is satisfactory that 75% 
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of the MOU patients described above had the partogram completed.  This differs from the 
conclusion of a study done (in the same district) by Jagau et al. in 2017 which showed that a 
much lower proportion of partograms were completed in the MOU setting (Kalume 
Kalangula, 2008: 25-26; Kurinczuk, White-Koning & Badawi, 2010: 336; Jagau et al., 2017: 
135). 
 
6.6  FETAL CARE ASPECTS OF LABOUR     
The MOUs and MMH both had FHR monitoring for all their patients in labour. Of note all 
patients referred from the MOU in labour had been admitted in latent labour; this means that 
they did not present in advanced labour where there was no time for monitoring before 
delivery. The MOU referred patients all had monitoring by IA except for three patients who 
had CTGs and the latter had CTG monitoring in all patients.  The use of these methods are 
appropriate for the risk of the patient i.e. low risk patients getting IA which is supported by 
the 2017 Cochrane review and the 2018 study by Smith et al.  These publications showed that 
the admission CTG (aCTG) is of no benefit and one cannot justify its use; the use of the CTG 
and the use of IA revealed no differences in the outcome of obstetric and neonatal care 
(Devane et al., 2017: 2; Smith et al., 2018: 114).  In contrast, continuous CTG monitoring is 
recommended in high risk patients, thus the 100% use of CTGs at MMH is acceptable 
(Mahomed et al., 1994: 497). 
Looking at MOU practices, 70% of patients who were in spontaneous latent phase had FHR 
monitoring done adequately whereas only 37.5% had adequate FHR monitoring in the active 
phase of labour.  This is in-keeping with the Jagau et al study which demonstrated that FHR 
monitoring was not done according to protocol (by use of the partogram) even though HCW 
understood the importance of correct and timely monitoring.  In addition, that study showed 
that HCW felt that they had too little time in which to monitor adequately and some felt 
insecure in their ability of FHR documentation (Jagau et al., 2017: 135). 
At MMH, there were several factors which affected adequate CTG monitoring and 
management of patients.  These included a poor quality tracing of the CTG, with loss of 
contact of the probe on the patient’s abdomen, incorrect interpretation by attending HCW, 
and infrequent reviews of CTGs.  In approximately 74% of patients the CTG was fully 
documented, in accordance to protocol, in the clinical notes.  In 26% of patients the CTG 
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were not reviewed or findings were not documented or described in the notes. All of these 
factors would lead to delayed response or action to FH abnormality. 
Furthermore, 40% of our study patients had MSL which corroborated with the Bruckmann & 
Velaphi study which showed about 34% of cases and the Kalume Kalangula study showing 
35% of cases having MSL.  The Martinez-Biarge study had fewer patients (29%) with MSL.  
Moreover, about 94% of patients in our study had abnormal CTGs, this was much higher than 
the 47% of cases found in the Bruckmann & Velaphi study and the 73% of cases shown in 
the Kalume Kalangula study (Bruckmann & Velaphi, 2015: 300; Kalume Kalangula, 2008: 
26; Martinez-Biarge et al., 2013: e955). 
Approximately 87% of patients in our study with abnormal CTGs, had documented evidence 
of having received intrapartum resuscitation (IPR). 
 
6.7  MOU REFERRALS 
 Metro West has a tiered referral system which is governed by well-defined referral criteria 
and requires emergency transport between levels of care.  The MOUs manage the low risk 
patients in labour and all of the antepartum patients over 36 weeks gestation.  Prior to this, 
the basic antenatal care (BANC) sites manage the low risk antenatal patients under 36 weeks.  
Once a complication is diagnosed, the MOU midwives will discuss the patients with the 
doctors at their referral hospital for possible transfer. The urgency of the referral will be 
discussed with the referral hospital and appropriate transport organised. The most urgent 
transport is the ‘flying squad’, which is no longer a dedicated obstetric ambulance, but refers 
to the most urgent ambulance which should arrive at the referring MOU to collect the patient 
within 30 minutes of request. It is indicated for conditions such as cord prolapse, eclampsia, 
haemorrhage, prolonged second stage and pathological fetal heart rate.  
In our study, we had 10 patients with abnormal FHR who were referred.  The time it took 
from ambulance dispatch time to arrival time at MMH, after collecting the patient from an 
MOU, ranged from 38 to 114 min, with a mean of 66 min.  This is the norm for referrals in 
our setting where some MOUs are at least 20 kms from MMH; but a two hour delay in cases 
of abnormal FHR could prove critical for these neonates.  If one looks at all the referrals, the 
dispatch to arrival time ranged from 27 to 191 min, with a mean of 66 min.  Again 191 mins 
is too long for an urgent referral such as cord prolapse. It has been suggested in SA, that the 
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new model of maternity care should be for Onsite Midwife Birthing Units (OMBUs) instead 
of the current system of stand-alone MOUs that exist in Cape Town. OMBUs would allow 
for more rapid referrals and earlier intervention for obstetric emergencies. 
 
6.8  MODE OF DELIVERY 
Caesarean section was performed for 58.3% of the patients in our study.  This figure is 
comparable with the study done in the United Kingdom (UK), by Martinez-Biarge et al., 
where 50% of the cases had emergency CS. However it is much more than the 38% found in 
both the previous MMH study and the Bruckmann & Velaphi study.  In addition, much lower 
proportions of cases required CS in the Nepal and West Australia studies which were 6.7% 
and 9.5% respectively.  The leading indication for CS in our study was pathological CTG 
(71.4%), in contrast to the 15% in the previous study.  The indications for CS in our study 
and that of the previous study had interesting differences.  The previous study cited CPD, 
failed vaginal birth after Caesarean (VBAC) and failed IOL as frequent indications for CS, 
requiring CS whereas we had none for these indications.  Our main indications for CS, in 
addition to pathological CTG, were suspected abruptio placentae, cord prolapse, eclampsia 
and prolonged second stage.  Our indications were mostly sentinel events and had a greater 
urgency for the need for CS.  The indications for CS were not highlighted in the other studies 
described. It is difficult to interpret this finding on different indications for CS compared to 
the previous study; it could be that doctors are acting much earlier on CTG signs than 
previously and intervening before prolonged labour ensues, or it could be that there is a 
higher burden of high risk pregnancies with hypertension, abruptio placenta and IUGR all 
rendering the fetus more vulnerable to hypoxia.  Assisted delivery, mostly ventouse delivery  
accounted for 14.6% of the deliveries in the current study, this is similar to the previous 
MMH study (15%), but nearly double that of the Bruckmann & Velaphi study (8.7%).  The 
indications for assisted delivery in our study were all for fetal distress, except one which was 
for prolonged second stage of labour.  In the current study 27.1% of patients had a vaginal 
delivery.  This was about a fifth and a sixth less than that of the Kalume Kalangula study and 
the Bruckmann & Velaphi study respectively, however more or less in keeping with the 
Martinez-Biarge study  (Martinez-Biarge et al., 2013: e955; Kurinczuk, White-Koning & 
Badawi, 2010: 336-337; Bruckmann & Velaphi, 2015: 300; Kalume Kalangula, 2008: 27). 
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It is possible that more CS are being done earlier for suspected perinatal hypoxia; this could 
reduce the fresh stillbirth and early neonatal death rates, but not reduce (or even increase) the 
NE rate. Also, earlier intervention could reduce the severity of the NE (i.e. from severe to 
mild) and thus would be an important intervention.  
The findings of  both an increased NE rate and increased CS rate needs to be explored further 
and compared with any trends in reduction of perinatal deaths due to hypoxia and also any 
changes in the severity of NE.  
 
6.9  SENTINEL EVENTS 
Major obstetric complications which may occur in a previously low risk patient are called 
sentinel events.  These may result in hypoxic-ischaemic changes in the fetal and /or neonatal 
brain (Martinez-Biarge et al., 2011: 1.e1). In our study, there were sentinel events for only 
31.3%, which is less than the previous MMH study and that by Martinez-Biarge. Martinez-
Biarge et al. showed that sentinel events contributed to most (71%) of their neonates with 
NE, of which, uterine rupture and abruptio placentae were the most frequent sentinel events 
in their study.  They concluded that intrapartum events superseded antepartum factors for 
the development of NE (Martinez-Biarge et al., 2011: 1.e4,1.e6).  This fits with the Kalume 
Kalangula study where intrapartum factors contributed 59% and antepartum factors 12% 
respectively to NE (Kalume Kalangula, 2008: 27).  Indeed, this was also what our current 
study demonstrated with two thirds of sentinel events occurring in the intrapartum period 
while about one third occurred in antenatally.  The Western Australia study contradicted all 
the above studies in that they concluded that 69% of risk factors occurred in the antepartum 
period while intrapartum hypoxia alone, only contributed to 4% of NE (Badawi et al., 1998: 
1557). Our study nor the previous, did not take record cord blood gases which were not 
routinely done and could have contributed to identifying intrapartum factors. 
Looking more in-depth at the sentinel events, the most common occurring condition was 
prolonged second stage of labour in the previous MMH study (Kalume Kalangula, 2008: 
29).  However prolonged second stage of labour together with shoulder dystocia were 
equally the most frequent sentinel events in our study. Furthermore, what is interesting is 
that sentinel events contributed to 31.3% of all the neonates with NE in our study while in 
68.7% of patients, there was no demonstrable sentinel event.  Of the latter, 75.8% of the 
assessable CTGs were pathological.  Moreover, in our study, the proportion of patients with 
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no sentinel event had higher (32%) NE scores compared to the proportion (7.7%) who had 
sentinel events.  We can only postulate that with a sentinel event, which may be dramatic, 
the HCW is alerted, manages and intervenes quickly by expediting delivery, and  this may 
result in neonates having lower NE scores. 
 
 6.10  AVOIDABLE FACTORS 
It is important to look for possible factors that may have contributed to a poor outcome, in 
order for health care workers (HCW) to improve their management of pregnant patients.  
Further, it may help the healthcare system to optimise its resources (e.g. ambulance 
transport), and indeed, help us to empower our patients and educate them on possible danger 
signs in pregnancy.  In SA we use PPIP to audit our perinatal morbidity and mortality.  The 
programme was designed for us to record the number of deliveries in each district, report and 
record perinatal deaths, in particular looking at the causes of the deaths, but also to report the 
avoidable factors which were related to the deaths.  These are divided into patient-, 
administrative- and medical personnel-related factors (PPIP, 2013). We classified the 
avoidable factors in the same fashion in our study for NE cases. 
There was one patient related factor identified in our study, namely, infrequent visits to the 
ANC.  There may have been an under-recording of patient related factors by attending HCW, 
however the previous MMH study also found a low number of patient related avoidable 
factors compared to those of the medical personnel. 
The administrative avoidable factors were mainly due to problems with transport and 
availability of theatre facilities.  There was an ambulance delay in nearly 43% of the cases, 
which is in vast contrast to 9% found in the previous study.  This may be due to  an increase 
in service demands  due to more patients in the system, more deliveries and perhaps more 
referrals in general because of higher disease burden due to, for example obesity which has 
increased substantially over the past decade.  Furthermore, MMH’s increase in workload may 
be evidenced by 25% of patients having delayed access to the OTs because they were 
occupied. MMH has two OTs, one is closed after hours, but can be opened for a dire 
emergency, but this involves getting another anaesthetic doctor from GSH, mobilising 
nursing staff from other areas in the hospital, and having sufficient obstetric doctors to man 
two OTs.  It is somewhat worrisome that in 28.6% of patients needing a CS, the reason for 
the delay was not documented.  This needs to be addressed and one would hope that the delay 
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is not due to long turnover times in OT nor the non-urgency of staff in LW preparing the 
patient for OT.  This needs to be explored further. 
A large number of patients had inadequate FHR monitoring at both the MOU and at MMH.  
At the MOU, all patients had FHR monitoring in the latent and active phase of labour, 
however the quality was poor.  Monitoring in the latent phase was inadequate in 30% and in 
the active phase it was 62.5% of patients.  The latter may be an indication of too few nursing 
staff on duty to ensure appropriate half-hourly monitoring of the FHR.  At MMH it was 
found that 27% of patients had a pathological trace that the HCW did not recognise to be a 
problem.  This in turn would delay appropriate management with IPR and expediting 
delivery.  Further, 20.8% of patients had a delay in the attending doctor’s initial assessment 
(> 60 min) upon arrival at MMH.  In summary, there were 75% of instances where medical 
related avoidable factors played a role, this was higher than in the previous study with 
medical personnel contributing to 65% of the avoidable factors.  What could be the reason for 
this increase?  Perhaps with an increase in workload, as alluded to above, adequate 
monitoring and the correct management of patients becomes compromised. This also needs to 
be explored further. 
 
 6.11  NEONATAL CHARACTERISTICS AND OUTCOMES 
There were 64.6% male neonates who had NE compared to 35.4% of female in our study.  
This is comparable to the CHBAH study but differs from the study conducted in the UK 
where their female to male ratio was about 50/50.  In our present study the average birth 
weight was 3169g which is similar to the CHBAH (3084g) study.  The UK study had an 
average birth weight of 3320g, slightly higher than the SA studies. 
 The average Apgar score at one, five, 10 minutes were three, six, seven respectively.  There 
were 57.4% of neonates who had a score of less than seven at five min and 34.8% had an 
Apgar score of less than seven at 10 min, compared to the Bruckmann & Velaphi study, they 
had about 68% of neonates with a five min Apgar score of less than seven and about 30% had 
scores of less than seven at 10 min ((Bruckmann & Velaphi 2015: 300; Martinez-Biarge et 
al., 2013: e955).   
The maximum NE scores were recorded in 38 patients in our study.  The majority (76.3%) 
had a mild NE score, according to the Thompson NE scoring system.  A moderate NE score 
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was found in 10.5% of neonates whereas 13.2% had a severe NE score. Although there was a 
tendency for higher NE scores to be associated with absence of sentinel events, this was not 
statistically significant due to small numbers.   
We did not assess the neonatal management or outcomes in our study thus cannot comment 
on these. This was not within the scope of this study which concentrated on obstetric factors 
occurring in NE. 
We looked at the number of deliveries there were during the shift hand over period i.e. 6:00-
8:00 am and 6:00-8:00 pm as, anecdotally, this time seems to be the troublesome time. This is 
when continuity of care is interrupted with possible resultant poor monitoring of the patients 
in labour. It was found that 16.7% of deliveries occurred at this time, about 10% after night 
shift and about 6% after day shift.  This is not a large proportion of deliveries, but would be  
interesting to follow up, with a consideration of introducing staggering of nursing staff shifts. 
 
 6.12  LIMITATIONS OF THE STUDY  
There are several limitations of this research study. It is a descriptive and retrospective study 
with no control or comparison group, so the risk factors for NE could not be assessed.  
Further, the study population was small in number, limiting further statistical analyses of sub-
categories of data. Since it involved a retrospective folder review, not all the required data 
was available. Details of cord blood gases were not routinely documented.                                                                                                                                        
The purpose of this research was to audit the obstetric factors in NE, and details of neonatal 
follow-up, and outcomes were not included. This means that obstetric factors, such as 
sentinel events, could not be related to neonatal outcomes.  
 
6.13  RECOMMENDATIONS 
It is recommended that ongoing partogram and CTG training for both nursing and medical 
staff occurs at regular intervals.  This will be of value as MMH has a rapid turnover of staff 
particularly in LW and OT. 
In addition, on-going antenatal training is recommended, particularly more awareness of 
prolonged pregnancy and the necessary referral for induction of labour needs to be made 
timeously.  Furthermore, since a large proportion (50%) of the patients were primigravid, 
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HCWs should be vigilant when managing them in the antenatal and intrapartum period.  
Similarly, since obesity made up nearly 30% of the study population, antenatal education of 
patients should include promoting a healthy lifestyle by restricting excessive high caloric 
diets and staff should pay special attention to their management.                                                                                                                                
Liaison with Emergency Medical Services (EMS) to improve emergency transport is needed.                                                         
Policy changes promoting OMBUs rather than stand-alone primary care MOUs should be 
considered in future planning.                                                                                                         
Since many patients were delayed in accessing theatre for emergency CS, it may be 
advantageous to explore how it would be possible to have both theatres available 24 hours a 
day.                                                                                                                                                       
The importance of detailed documentation is indispensable, not only in helping to identify 
modifiable factors but also if there are medico-legal sequelae around such cases.                                                                                                    
Future research on risk factors with a case control design and exploration of the health system 
factors identified is indicated. 
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7. CONCLUSION  
In this study we have shown that the NE rate for MMH is 5.5 per 1000 LBs, this is higher 
than the previous 2008 MMH study, despite a higher CS rate. This is likely to be partly due to 
an increase in the identification of mild NE as mentioned. Whether this in fact also reflects a 
deterioration of care, or is associated with a concomitant reduction in perinatal hypoxic 
mortality needs to be explored. The study design was unable to identify demographic risk 
factors but of note, all patients were booked for antenatal care and none had congenital 
infections such as syphilis. Prolonged pregnancy and hypertension were the most common 
antenatal complications. The majority of patients who had infants with NE were in 
spontaneous labour arriving timeously at the facility, and half of these were referred during 
labour from MOUs. Sentinel events for NE occurred in 31.3%; one third were antenatal and 
two thirds were intrapartum. Although 68.7% had no sentinel events, it was noted that 
abnormal CTGs occurred in 75.8% of this group, indicating the importance of intrapartum 
factors in this cohort of NE cases. In particular, prolonged second stage of labour and 
shoulder dystocia were identified as the most frequent intrapartum sentinel events, with 
abruptio placentae, eclampsia and cord prolapse being other less frequent events. Important 
avoidable factors identified included inadequate FHR monitoring at the MOUs, poor 
recognition of abnormal CTGs at MMH, inter-institution transport delay, and delay in 
accessing theatre for emergency CS.  The obstetric management in our district may improve 
with regular and ongoing intrapartum care training for medical and nursing staff and 
addressing the health system issues identified. 
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3. PPIP (Perinatal problem identification programme) AVOIDABLE FACTORS
Avoidable factors Code list version: Please note that PPIP does not allow you to 
enter a group heading. You must select an individual item which 3.00 describes 
the avoidable or modifiable factor. 
Code Description 
0100 PATIENT ASSOCIATED 
0101 Never initiated antenatal care 
0102 Booked late in pregnancy 
0103 Infrequent visits to antenatal clinic 
0104 Failed to return on the prescribed date 
0105 Inappropriate response to rupture of membranes 
0106 Inappropriate response to antepartum haemorrhage 
0107 Inappropriate response to poor fetal movements 
0108 Delay in seeking medical attention during labour 
0109 Delay in seeking help when baby ill 
0110 Declines admission/treatment for personal/social reasons 
0111 Partner/Family declines admission/treatment 
0112 Alcohol abuse 
0113 Smoking 
0114 Illegal drug use 
0115 Assault 
0116 Attempted termination of pregnancy 
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0117 Infanticide 
0118 Abandoned baby 
0199 Other patient associated factors 
0200 ADMINISTRATIVE PROBLEMS 
0201 Lack of transport - Home to institution 
0202 Lack of transport - Institution to institution 
0203 Lack of adequate neonatal transport 
0204 No syphilis screening performed at hospital / clinic 
0205 Result of syphilis screening not returned to hospital/clinic 
Printed by PPIP3.0 on 1 24/09/2013 Page 
Avoidable factors Code list version: Please note that PPIP does not allow you to 
enter a group heading. You must select an individual item which 3.00 describes 
the avoidable or modifiable factor. 
Code Description 
0206 No on-site syphilis testing available 
0207 No Motherhood card issued 
0208 No dedicated high risk clinic at referral hospital 
0209 Inadequate facilities/equipment in neonatal unit/nursery 
0210 Inadequate theatre facilities 
0211 No accessible neonatal ICU bed with ventilator 
0212 Inadequate resuscitation equipment 
0213 Insufficient blood / blood products available 
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0214 Insufficient nurses on duty to manage the patient adequately 
0215 Insufficient doctors available to manage the patient 
0216 Personnel not sufficiently trained to manage the patient 
0217 Personnel too junior to manage the patient 
0218 Staff rotation too rapid 
0219 Anaesthetic delay 
0220 Theatre delay: staff not available 
0221 Theatre delay: all theatres occupied 
0222 Congenital abnormality not diagnosed: No ultrasound service available 
0299 Other administrative problems 
0300 MEDICAL PERSONNEL ASSOCIATED 
0301 No response to history of stillbirths, abruptio etc. 
0302 No response to maternal glycosuria 
0303 No response to poor uterine fundal growth 
0304 No response to maternal hypertension 
0305 No response to positive syphilis serology test 
0306 No response to apparent postterm pregnancy 
Printed by PPIP3.0 on 2 24/09/2013 Page 
Avoidable factors Code list version: Please note that PPIP does not allow you to 
enter a group heading. You must select an individual item which 3.00 describes 
the avoidable or modifiable factor. 
Code Description 
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0307 No response to history of poor fetal movement 
0308 No antenatal response to abnormal fetal lie 
0309 Multiple pregnancy not diagnosed antenatally 
0310 Physical examination of patient at clinic incomplete 
0311 GP did not give card/letter about antenatal care 
0312 Medical personnel overestimated fetal size 
0313 Medical personnel underestimated fetal size 
0314 Fetal distress not detected antepartum; fetus monitored 
0315 Fetal distress not detected antepartum; fetus not monitored 
0316 Antenatal steroids not given 
0317 Poor progress in labour, but partogram not used 
0318 Poor progress in labour, but partogram not used correctly 
0319 Poor progress in labour - partogram interpreted incorrectly 
0320 Fetal distress not detected intrapartum; fetus monitored 
0321 Fetal distress not detected intrapartum; fetus not monitored 
0322 Breech presentation not diagnosed until late in labour 
0323 Multiple pregnancy not diagnosed intrapartum 
0324 Incorrect management of hypertensive disease 
0325 Incorrect management of antepartum haemorrhage 
0326 Incorrect management of premature labour 
0327 Incorrect management of cord prolapse 
0328 Iatrogenic delivery for no real reason 
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0329 Management of 2nd stage: prolonged with no intervention 
0330 Management of 2nd stage: inappropriate use of forceps 
0331 Management of 2nd stage: inappropriate use of vacuum 
0332 Neonatal resuscitation inadequate 
Printed by PPIP3.0 on 3 24/09/2013 Page 
Avoidable factors Code list version: Please note that PPIP does not allow you to 
enter a group heading. You must select an individual item which 3.00 describes 
the avoidable or modifiable factor. 
Code Description 
0333 Neonatal care: inadequate monitoring 
0334 Neonatal care: management plan inadequate 
0335 Baby managed incorrectly at Hospital/Clinic 
0336 Baby sent home inappropriately 
0337 Delay in doctor responding to call 
0338 Doctor did not respond to call 
0339 Delay in medical personnel calling for expert assistance 
0340 Delay in referring patient for secondary/tertiary treatment 
0341 Nosocomial infection 
0342 Inadequate / No advice given to mother 
0343 Congenital abnormality not diagnosed; U/S examination not performed 
0344 Congenital abnormality not diagnosed; U/S examination was performed 
0399 Other medical personnel associated factors 
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0400 INSUFFICIENT NOTES TO COMMENT ON AVOIDABLE FACTORS 
0401 Insufficient notes 
0402 File missing 
0403 Antenatal card lost 
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4. HPIP MATERNAL CASE REVIEW  
Criteria to be met for completion 
A gestational age of ≥ 36 weeks (or ≥1.8kg if unsure gestation) 
Encephalopathy meeting cooling criteria* with or without aEEG assessment 
* <6 hours after birth: and absence of: severe congenital anomaly, uncontrolled bleeding, 
uncontrolled systemic hypotension, and pulmonary hypotension not responding to treatment 
Suspected intra-partum hypoxia based on: 1st hour  pH < 7.0 or BD ≥ 12 mmol/l; or 5-min Apgar < 7 
or assisted ventilation at 10 min 
Data to be entered after discussion at a multi-discipline morbidity review meeting that includes at 
least an obstetrician/MO with extensive obstetric experience/Family Physician specialist; a midwife 
and a paediatrician/ MO with extensive paediatric experience/Family Physician specialist 
Form completed by: 
Date Completed (Date): 
Mother's Name and Surname: (assume already recorded as per ECCR) 
Mother's Folder Number: (ditto) 
Mother's Date of Birth: (ditto) 
Baby's Folder Number: Able to be located via Clinicom 
 
Date and time of admission to first intrapartum care facility: (Date; Time) (completed by form filler 
and NOT populated from Clinicom) 
Delivery Date and Time (Date; Time) as above 
Place of Delivery (At this facility/at home/in transit/another facility/unknown ) as above 
 
Pregnancy 
Pregnancy History (Include this birth)(Gravity and Parity) 
Previous Caesarean Section?(Yes/No) 
Antenatal risk factors (tick all that may apply): 
❏ Unbooked 
❏ Gestational hypertension 
❏ Diabetes mellitus/Impaired glucose tolerance 
❏ Diabetes mellitus 
❏ Small for gestational age 
79 
 
❏ Untreated/Incompletely treated syphilis at the time of delivery 
❏ Smoker 
❏ Substance abuse (including alcohol) 
❏ Abdominal trauma during antenatal period requiring admission to hospital 
❏ Antepartum haemorrhage 
❏ Body Mass Index >35kg/m2 
❏ Multiple pregnancy 
❏ Any anomalies on ultrasound (would need a section of free text to describe this) 
❏ Other maternal disease (describe in free text section) 
❏ Postdates (> 42 weeks with certain gestation) 
❏ Other (describe in free text section) 
 
Gestation at time of delivery (weeks) 
Gestation assessed by: 
❏ Dates 
❏ SF Height 
❏ Ultrasound before 24 weeks 
❏ Ballard Score/Foot Length 
  
Any risk factors for or features of clinical chorioamnionitis (tick all that apply): 
❏ None 
❏ Maternal Pyrexia >38 degrees during labour 
❏ Maternal Tachycardia ≥120 bpm 
❏ Fetal Tachycardia >160 bpm during labour  
❏ Offensive liquor  
❏ Uterine irritability/tenderness 
❏ Membrane rupture at time of delivery >18 hours 
 
REFERRING FACILITY: 
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BANC+ CLINIC/MOU/DISTRICT 
HOSPITAL/REGIONAL HOSPITAL 
Any intrapartum care received at referring facility? (Yes/No) 
Which institution? 
Was there evidence of Fetal Distress on presentation to the facility? 
(Yes/No/Insufficient Information) 
Partogram correctly completed during labour? 
(Yes/No*/Insufficient Information*) 
[*will need to add to avoidable factors] 
Evidence of Fetal Heart Monitoring (fetoscope/Doptone/CTG)? 
(Yes/No*/Insufficient Information*) 
[*will need to add to avoidable factors] 
Abnormal fetal heart rate recorded? 
(Yes/No/Insufficient Information) 
Fetal Distress Possibility? (Abnormal Heart rate, MSL) 
(Yes/No/Insufficient Information) 
Recorded reason for referral  
(reason) 
Was the referral timeous (as judged by the M&M meeting?) 
(Yes/No*/Insufficient Information*) 
[*will need to add to avoidable factors at end of form] 
 
Transport 
Emergency Medical Transport to Hospital prior to delivery?(Yes/No) 
Call to Metro date and time (date; time) 
Dispatch date and time (date; time) 
Labour Ward arrival date and time (date; time) 
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Birth Institution 
Name: (Free text or drop down with option for Other with free text. List 
NSH/MMH/TBH/KDH/GSH/KBH/MPDH/Other) 
First Nurse Assessment time (date; time) 
First Doctor Assessment time (date; time) 
 
Labour 
 
Ever in Labour? (Yes/No) 
If yes, Labour Initiation (Spontaneous/Induced) 
 
 If induced, methods used (leave blank if not induced) 
❏ AROM 
❏ Prostaglandin E1 (Misoprostol) 
❏ Oxytocin 
❏ Intra-cervical bulb-catheter 
❏ Prostaglandin E2 
 
1st Stage Duration (in hours) (leave blank if not known) 
2nd Stage Duration (in hours and minutes) (leave blank if not known) 
Augmentation with oxytocin ever used?  
If oxytocin used for augmentation, was the use appropriate? (Yes/No*) 
[*will need to add to avoidable factors] 
 
Sentinel events during labour or delivery: (tick if appropriate) 
❏ Cord prolapse 
❏ Significant antepartum haemorrhage 
❏ Eclamptic convulsion 
❏ Clinical abruptio placentae 
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❏ Shoulder impaction 
❏ Prolonged second stage  
 
Meconium Stained Liquor ever? (Yes/No/Insufficient Information) 
Intrauterine resuscitation ever indicated? (Yes/No/Insufficient Information) 
Intrauterine resuscitation used? (Yes/No/Insufficient Information) 
Intrauterine resuscitation methods employed? (tick for yes, leave blank if not applicable) 
❏ Tocolysis if applicable (if yes specify salbutamol/nifedipine) 
❏ Augmentation stopped 
❏ Mother's position changed 
❏ Fluid bolus 200ml given 
Was there a documented response to the intra-partum resuscitation? (Yes/No/Insufficient 
Information) 
 
Fetal Monitoring during labour 
Fetal heart rate recorded at birthing institution? (Yes/No) 
Frequency of FH monitoring (according to level of care of patient): 
2 hourly in latent labour (low risk patient) or hourly (high risk) – n/a; not documented / partially 
done, always done 
Half hourly in active labour (low risk) or every 15 minutes (high risk- preferably continuous CTG) – 
n/a; not documented/ partially done, always done  
CTG used ever? (Yes/No)- branching algorithm 
First CTG time (Leave blank if not performed/not documented) 
Documented Evidence of intrapartum CTG review? (Yes/No/Insufficient Information) 
Last performed CTG classification? (Normal/Non-reassuring/Abnormal) 
On formal review, was there ever an error interpreting the CTG? 
Describe (free text section needed) 
On formal review, was the combination of clinical context and CTG interpretation acted on 
appropriately? (Yes/No/Insufficient Information) 
Other—specify 
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Staffing 
Most senior nurse caring for patient or documented as consulted during Labour 
(Midwife/Registered Nurse/Enrolled Nurse/Agency Nurse/Nursing student/None/Never in Labour) 
Most senior nurse present at Vaginal Birth  
(Midwife/Registered Nurse/Enrolled Nurse/Agency Nurse/Nursing student/not a Vaginal Birth)  
Most Senior obstetric doctor managing or consulted about intrapartum care? (Obstetrician/Family 
Medicine Specialist/Registrar/Medical Officer/Intern/No doctor involved intrapartum care) 
Most Senior obstetric doctor present at Vaginal Birth? (Obstetrician/Family Medicine 
Specialist/Registrar/Medical Officer/Intern/No doctor present/not a Vaginal Birth) 
Specialist Obstetrician consulted at any point in labour? (Yes/No) 
 
 
Delivery  
Any attempt made to perform an Assisted Vaginal Delivery using either Vacuum Extraction or 
Forceps? [Algorithm branch] 
Assisted Vaginal Delivery  
Attempted? (Yes/No) 
Indication (Prolonged 2nd stage/ Maternal Exhaustion/Fetal Distress/Other) 
Method (Vacuum/Forceps) 
Were the necessary pre-requisites for instrumental delivery met and noted? 
On review, indication for instrumental delivery correct? (Yes/No) 
Adequate documentation describing procedure? (Yes/No) 
Successful? (Yes/No) 
Protocol adhered to? (Yes/No) 
Mode of Delivery (Vaginal Vertex/Vaginal Breech/Elective Caesarean Section/Emergency Caesarean 
Section in labour/Emergency Caesarean Section not in labour/Assisted delivery (Forceps/Vacuum 
Extraction)) Branching algorithm 
 
Caesarean Section 
Decision time documented? (Yes/No) 
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Decision time (Date; time) 
Decision time to delivery? 
If Decision time to delivery time >60 minutes, what were the reasons (No reason given/Labour ward 
theatre occupied/All possible theatres occupied/Difficult surgery/Delay in preparing patient for 
theatre/Anaesthetic delay/Not known) 
Indication for Caesarean Section? (Previous Caesarean Section/Abnormal placentation/Fetal 
Distress/Cephalopelvic disproportion/Maternal Choice/Malpresentation/Failed induction of 
labour/Failed attempt at Assisted Vaginal Delivery/Multiple pregnancy/Other______) 
 
 
Summary of Review 
A. Likely cause of HIE (please circle more than one if the case) (multiple choices allowed) 
--vulnerable fetus (eg IUGR, prolonged pregnancy) 
-prolonged labour with evidence of fetal compromise 
-prolonged second stage with evidence of fetal compromise 
-cord accident  
-abruptio placentae 
-ruptured uterus 
-eclamptic convulsion 
-maternal collapse/severe maternal disease 
-hyperstimulation syndrome on CTG without evidence of fetal recovery 
-not related to intra-partum events 
 
 
B. Modifiable Factors 
(Please reference Avoidable Factors in PPIP Code list Version 3.0) 
[To have option of adding multiple with drop down list in electronic form] 
 
[Amended PPIP code list attached for these factors with additional codes addressing delays 
added using new codes 342-345) 
 
Additional PPIP codes (under heading 300 Medical Personnel) (multiple choices allowed) 
342 Delay in patient being assessed on arrival at birthing institution 
343  Abnormal CTG record not reviewed timeously 
344 Incorrect CTG interpretation 
345  Delay in definitive action/Caesarean Section once abnormality detected 
346  No delays with everything performed timeously 
 
 
 
